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ABSTRACT: The first [4+2]-annulation between aminocyclobutanes and aldehydes to access tetrahydropyranyl amines is report-
ed. With phthalimido cyclobutane dicarboxylates and aromatic aldehydes, tetrahydropyrans were obtained in 53-92% yield and 3:1-
17:1 dr using scandium triflate or iron trichloride as catalyst. The use of thymine- or fluorouracil- substituted cyclobutanes gave 
direct access to six-membered ring nucleoside analogues. Finally, the [4+2]-annulation between aminocyclobutanes and enol ethers 
led to the corresponding cyclohexylamines. 
Six-membered nitrogen-substituted carbo- and heterocycles 
are among the most frequently encountered scaffolds in natu-
ral and synthetic bioactive compounds (Figure 1). A cyclo-
hexylamine or a tetrahydropyranylamine ring for example can 
be found in the core of the natural alkaloids strychnine (1) and 
staurosporine (2) respectively. The synthetic antiviral drug 
Tamiflu (3) is constituted by a cyclohexenyldiamine core. 
Synthetic methods giving access to these important scaffolds 
with high efficiency and broad scope are desirable to acceler-
ate the discovery of new bioactive compounds. Whereas the 
Diels-Alder reaction has emerged as a powerful method to 
synthesize cyclohexenylamines and dihydropyranylamines,
1
 
there is currently a lack of transformations giving straightfor-
ward access to saturated ring systems with high convergence.
 
 
Figure 1. Bioactive compounds containing nitrogen-
substituted six-membered rings.  
The use of annulation reactions of donor-acceptor substitut-
ed strained rings constitutes a valuable alternative for the syn-
thesis of saturated carbo- or heterocycles. In the case of six-
membered rings, the [4+2]-annulation between donor-acceptor 
cyclobutanes and olefins or carbonyl compounds appears par-
ticularly attractive (Scheme 1, A). Nevertheless, the chemistry 
of donor-acceptor cyclobutanes has been much less developed 
than for the corresponding cyclopropanes.
2
 It is only very re-
cently that more general catalytic methods have been devel-
oped in the groups of Johnson, Christie and Pritchard, and 
Pagenkopf in particular (Scheme 1, B).
3
 However, these works 
focused on the use of oxygen and carbon as electron-donating 
groups, and the scope of substituents on the cyclobutanes was 
often limited. In the case of nitrogen as donor, an important 
pioneering result has been reported by Saigo and co-workers 
in 1991.
4
 Unfortunately, the precious nitrogen functionality 
could not be conserved in the final product, as hydrolysis oc-
curred upon work-up. 
Scheme 1. [4+2]-Annulations for the Synthesis of Six-
Membered Rings. 
 
Recognizing the underexploited potential of nitrogen-
substituted strained rings for the synthesis of bioactive com-
pounds,
5
 our group has initially focused on the discovery of 
new types of donor-acceptor systems which could be broadly 
applied in annulation reactions. In particular, we reported that 
imido-substituted cyclopropane dicarboxylates can be used in 
[3+2]-annulations with both enol ethers and carbonyl com-
pounds under mild catalytic conditions.
6
 In 2013, we reported 
a new method to access the corresponding imido substituted 
cyclobutane dicarboxylates.
7
 A single example of [4+2]-
annulation between an aminocyclobutane and an enol ether 
 was also described in this work. Herein, we report the first 
Lewis acid-catalyzed [4+2]-annulation reaction between do-
nor-acceptor aminocyclobutanes and carbonyl compounds and 
a further extended  scope of the reaction with enol ethers 
(Scheme 1, C). In the case of aldehydes, the reaction was also 
successful for multi-substituted aminocyclobutanes, leading to 
tetrahydrofurylamines bearing up to three distinct stereocen-
ters. 
We stared our investigations by examining the [4+2]-
annulation of aminocyclobutane 4a,
7
 and benzaldehyde 5a 
(Table 1). The reaction proceeded with 20 mol % FeCl3•Al2O3 
as catalyst, which had been used in the corresponding reaction 
with aminocyclopropanes,
6c
 but the product was obtained only 
with low diastereoselectivity as part of a complex mixture 
(Table 1, entry 1). A higher diastereoselectivity (6:1) was ob-
served with tin tetrachloride, previously used for the single 
example reported of [4+2]-annulation of enol ethers and ami-
nocyclobutanes (Table 1, entry 2).
7
 However, a complex mix-
ture was also observed in this case. As the use of titanium tet-
rachloride did not lead to any improvement (Table 1, entry 3), 
we then turned to well-established metal triflates as catalysts. 
Whereas no reaction was observed with ytterbium triflate (Ta-
ble 1, entry 4) and a complex mixture was obtained with haf-
nium triflate (Table 1, entry 5), both indium and scandium tri-
flates led to complete conversion without the formation of side 
products (Table 1, entries 6 and 7). A better diastereoselectivi-
ty (13:1 vs 9:1) was observed in the case of scandium triflate.  
Table 1. Optimization of the [4+2]-Annulation. 
 
entry 4, R catalyst time conversiona drb 
1 4a, H FeCl3•Al2O3 40 min >95%
c 2:1 
2 4a, H SnCl4 2.5 h >95%
c 6:1 
3 4a, H TiCl4 2.5 h 88%
c 5:1 
4 4a, H Yb(OTf)3 2.5 h <5%
d - 
5 4a, H Hf(OTf)4 2.5 h >95%
c 9:1 
6 4a, H In(OTf)3 2.5 h >95% 9:1 
7 4a, H Sc(OTf)3 2.5 h >95% 13:1 
8e 4b, Me Sc(OTf)3 24 h <5%
d - 
9 4b, Me FeCl3•Al2O3 2.5 h 57% 1.5:1 
10 4b, Me FeCl3•Al2O3
f 5 h >95% 5:1 
aReaction conditions: 0.05 mmol 4, 0.075 mmol 5a, 20 mol % 
catalyst in 1.5 mL CH2Cl2 at rt. Conversion estimated by the ratio 
of product 6 to cyclobutane 4 on the 1H NMR of the crude mix-
ture. bDetermined on the 1H NMR of the crude mixture. cComplex 
mixture of products was observed by 1H NMR. dNo product ob-
served. eTemperature increased from rt to 40 °C after 7 h. f100 
mol % catalyst loading. 
When the methyl-substituted aminocyclobutane 4b was ex-
amined, the reactivity dropped significantly and no conversion 
was observed with scandium triflate (Table 1, entry 8). How-
ever, product 6ba could be obtained with 57% conversion and 
1.5:1 dr when using FeCl3•Al2O3 (Table 1, entry 9). Finally, 
increasing the amount of this cheap and non-toxic catalyst to 
100 mol % allowed us to reach full conversion and 5:1 dia-
stereoselectivity (Table 1, entry 10).
8
 
With optimized conditions in hand, we first examined the 
scope of the reaction of unsubstituted donor acceptor amino-
cyclobutanes (Table 2). On a preparative scale, tetrahydropy-
ranyl amine 6aa could be isolated in 92% yield and 16:1 dr in 
favor of the cis diastereoisomer (Table 2, entry 1).
9
 Electron-
withdrawing and donating groups in para position of the aro-
matic ring were well tolerated (Table 2, entries 2 and 3), alt-
hough a lower diastereoselectivity was observed in case of the 
methoxy substituent (Table 2, entry 3). Product 6ad bearing an 
ortho-methoxy substituent was obtained in 91% yield and 9:1 
dr (Table 2, entry 4). The [4+2]-annulation with cinnamalde-
hyde 5e proceeded in nearly quantitative yield, but with only 
2:1 dr. Under these reaction conditions, only low yields 
(<30%) and diastereoselectivities were obtained when using 
aliphatic aldehydes or ketones as partners (results not shown). 
We then turned to the more challenging use of substituted 
aminocyclobutanes. With cyclobutane 4b, the desired tetrahy-
dropyranyl amine 6ba was obtained in 64% yield as a 5:1 mix-
ture of only two diastereoisomers at the benzylic center (Table 
2, entry 6). The main product obtained corresponded to the 
isomer with all substituents in equatorial position, which is 
probably the most stable. The reaction was also successful 
with para-chloro benzaldehyde as partner (Table 2, entry 7). 
When using phenyl-substituted cyclobutane 4c, the reaction 
became slower. Nevertheless, the desired product 6ca could 
still be obtained in 53% yield (Table 2, entry 8). Finally, the 
annulation of cyclobutane 4d bearing a substituent in 3 posi-
tion relative to the phthalimide was examined (Table 2, entries 
9-10). This class of cyclobutanes can only be obtained as a 
mixture of diastereoisomers using our previously reported 
[2+2]-cycloaddition method.
7
 At room temperature, a signifi-
cant amount of retro [2+2]-cycloaddition was observed, but 
this side reaction could be suppressed at 0 °C. The desired 
products could then be obtained in 64-81% yield as a 3:1 mix-
ture of diastereoisomers starting from a 1:1.1 mixture of cy-
clobutanes. The annulation reaction is therefore not stereospe-
cific. Interestingly, we observed that the cis cyclobutane react-
ed faster than the trans isomer in the [4+2]-annulation. This 
difference in rate could be used to do a resolution of the diffi-
cult to separate isomers of aminocyclobutane 4d: with the less 
reactive indium triflate catalyst, the trans isomer of aminocy-
clobutane 1b could be recovered in quantitative yield and 14:1 
dr (Scheme 2). 
Scheme 2. Diastereospecific [4+2]-Annulation. 
 
During the investigation of the scope of the [4+2]-
annulation reaction of unsubstituted aminocyclobutanes, a rel-
atively high catalyst loading of scandium triflate (20 mol %) 
has been used for practical reasons. Nevertheless, the catalyst 
loading could be decreased to 5 mol % when the reaction was 
run on a 1 mmol scale and product 3aa was obtained in 81% 
yield and 13:1 dr (Scheme 3). 
 
 
 
 Scheme 3. [4+2]-Annulation at 1 mmol Scale. 
 
Table 2. Scope of the [4+2]-Annulation. 
 
entry aminocyclobutane product yield 
dra 
1 
 
 
92% 
16:1  
2 
 
 
75% 
17:1  
3 
 
 
82% 
6:1  
4 
 
 
91% 
9:1  
5 
  
95% 
2:1  
6 
 
 
64% 
5:1  
7 
 
 
62% 
5:1  
8 
  
53%b,c 
6:1 
9 
 
 
63%c,d 
3:1 
10 
 
 
81%c,d 
3:1 
aReaction conditions: With cyclobutane 4a: 0.20 mmol 4a, 0.30 
mmol 5, 0.040 mmol Sc(OTf)3 in 6 mL CH2Cl2, rt, 2 h. With cy-
clobutanes 4b-d: 0.20 mmol 4, 0.30 mmol 5, 0.20 mmol 
FeCl3•Al2O3 in 6 mL CH2Cl2, rt, 5 h. Isolated yield after column 
chromatography are given. b16 h reaction time. Structure not as-
signed due to peak overlap in 1H NMR. cProduct obtained in 
>90% purity by 1H NMR, dReaction mixture stirred for 2 h at 0 
°C.  
Recently, our group has discovered that phthalimide could 
be replaced by a protected thymine or uracil derivative in do-
nor-acceptor aminocyclopropanes to access nucleoside ana-
logues.
10
 We wondered if this approach could also be applied 
to the [4+2]-annulation. In view of the synthesis of bioactive 
compounds containing a tetrahydropyran ring, this is particu-
larly important, as the phthaloyl group cannot be removed on 
these substrates, in contrast to the corresponding carbocy-
cles.
6a,7
 Indeed, the reaction was successful with aminocyclo-
butane 4e bearing a benzoyl-protected thymine substituent 
(Scheme 4). In this case, best results were obtained using haf-
nium triflate as catalyst.
8
 As partial removal of the benzoyl 
group was observed during the reaction, the obtained crude 
mixture was directly treated with ammonium hydroxide in 
ethanol to obtain the fully deprotected product 6ea in 78% 
yield and 20:1 dr.
11
 The annulation with aminocyclobutane 4e 
was successful with aromatic aldehydes bearing an electron-
poor or electron rich benzene ring or a thiophene heterocycle, 
giving the desired products 6ec-d and 6f-g in 70-79% and 5:1-
12:1 dr. Cinnamaldehyde 5e could also be used to give 6ee, 
although the diastereoselectivity was lower, as in the case of 
the phthalimide substituted cyclobutane. Finally, the [4+2]-
annulation also proceeded with benzoyl protected fluorouracil 
derivative 4f (product 6fa). 
Scheme 4. Nucleoside Analogues via [4+2]-Annulation. 
 
Reaction conditions: 0.30 mmol 4, 0.45 mmol 5, 0.030 mmol 
Hf(OTf)4 in 6 mL CH2Cl2, rt, 15 min; then 1.8 mL 25% NH4OH 
solution, 6 mL EtOH, rt, 16 h. Isolated yield after column chroma-
tography and crystallization are given. 
Finally, we shortly examined the annulation reaction of enol 
ethers (Scheme 5). In this case, only tin tetrachloride at low 
temperature was successful as a catalyst. The reaction pro-
ceeded in high yield and diastereoselectivity with enol ethers 
substituted with a benzene derivative (products 8aa-c). How-
ever, the diastereoselectivity was lost when a more strongly 
electron-withdrawing group was present on the benzene ring 
 or when a 1,2-disubstituted enol ether was used (products 8ad 
and 8ae). The latter result demonstrated that the [4+2]-
annulation is not stereospecific in relation to the geometry of 
the enol ether, in contrast to the previously reported [3+2]-
annulation reaction.
6a
 The higher sensitivity of the enol ethers 
in comparison to the aldehydes did not allow the use of substi-
tuted cyclobutanes in the annulation process. 
Scheme 5. [4+2]-Annulation with Enol Ethers. 
 
Reaction conditions: 0.20 mmol 4a, 0.30 mmol 7, 0.040 mmol 
SnCl4, 4 Å MS in 2 mL CH2Cl2, -40 °C. Isolated yields after col-
umn chromatography are given. 
In conclusion, we have reported the first example of [4+2]-
annulation between aldehydes and donor-acceptor aminocy-
clobutanes which proceeds without loss of the precious nitro-
gen functionality. The reaction proceeded in high yield and 
diastereoselectivity with aromatic aldehydes when using un-
substituted phthalimido cyclobutane dicarboxylates. The annu-
lation was also successful when introducing substituents in 
1,2- or 1,3- positions to the phthalimide on the cyclobutane 
ring. The transformation could be as well applied to the syn-
thesis of six-membered ring carbonucleoside analogues. The 
[4+2]-annulation involving enol ethers appears more limited at 
this stage, as only unsubstituted cyclobutanes could be used 
successfully. Overall, our work demonstrated that the polariza-
tion concepts used in the case of aminocyclopropanes can be 
extended to their one-carbon homologues. Nevertheless, the 
lower reactivity of the aminocyclobutanes makes the use of 
sensitive reaction partners and the control of stereoselectivity 
more challenging than for the corresponding cyclopropanes. 
Experimental procedures and analytical data for all new com-
pounds. This material is available free of charge via the Internet at 
http://pubs.acs.org.   
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1. General Methods 
All reactions were carried out in oven- or flame- dried glassware under an atmosphere of nitrogen, unless 
stated otherwise. For quantitative flash chromatography, distilled technical grade solvents were used. 
THF, Et2O, toluene, hexane and CH2Cl2 were dried by passage over activated alumina under nitrogen 
atmosphere (H2O content < 7 ppm, Karl-Fischer titration). All chemicals were purchased and used as 
received unless stated otherwise. Chromatographic purification was performed as flash chromatography 
using Macherey-Nagel silica 40-63, 60 Å, using the solvents indicated as eluent with 0.1-0.5 bar pressure. 
TLC was performed on Merck silica gel 60 F254 TLC plastic or aluminium plates and visualized with UV 
light, permanganate CAN or p-anisaldehyde stains. Melting points were measured on a calibrated Büchi 
B-540 melting point apparatus using open glass capillaries. 1H-NMR spectra were recorded at room 
temperature on a Brucker DPX-400 400 MHz spectrometer in chloroform-d, all signals are reported in 
ppm with the internal chloroform signal at 7.26 ppm or DMSO signal at 2.50 ppm as standard. The data is 
being reported as (s = singlet, d = doublet, t = triplet, q = quadruplet, qi = quintet, m = multiplet or 
unresolved, br = broad signal, integration, coupling constant(s) in Hz, interpretation). 13C-NMR spectra 
were recorded with 1H-decoupling on a Brucker DPX-400 100 MHz spectrometer in chloroform-d, all 
signals are reported in ppm with the internal chloroform signal at 77.0 ppm or DMSO signal at 39.5  ppm 
as standard. Infrared spectra were recorded on a JASCO FT-IR B4100 spectrophotometer with an ATR 
PRO410-S and a ZnSe prism and are reported as cm-1 (w = weak, m = medium, s = strong). High 
resolution mass spectrometric measurements were performed by the mass spectrometry service of ISIC at 
the EPFL on a MICROMASS (ESI) Q-TOF Ultima API. Iron-Alumina complex was synthesized 
following the procedure of Tietze.1 Diastereoisomeric mixtures have been assigned by 2D NMR 
experiments including COSY/ROESY/HSQC/HMBC. Commercialy available N-Vinyl Phthalimide 
[3485-84-5], N-Vinyl-2-pyrrolidone [88-12-0], Diethyl Ethylidenemalonate [1462-12-0], Benzaldehyde 
[100-52-7], 4-Chlorobenzaldehyde [104-88-1], 4-Methoxybenzaldehyde [123-11-5], 2-
Methoxybenzaldehyde [135-02-4], and trans-Cynnamaldehyde [14371-10-9] were used. 
  
                                                          
1 Organic Syntheses, Vol. 71, p. 167 (1993); Coll. Vol. 9, p.310 (1998). 
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2. Synthesis of starting materials 
2.1 Synthesis of Enamides and Alkylidene Malonates 
(E)-2-(Prop-1-en-1-yl)isoindoline-1,3-dione (12) 
 
Following a modified procedure,2 allyl bromide (10) (2.6 mL, 30 mmol, 1.1 eq) was added dropwise at 
room temperature to a suspension of potassium phthalimide (9) (5.0 g, 27 mmol, 1 eq) and Bu4NI (0.50 g, 
1.4 mmol, 0.05 eq) in DMF (10 mL). The mixture was stirred for 20 h at room temperature, and then H2O 
(20 mL) was added. The precipitate was isolated by filtration, dried, and recrystallized from isopropanol 
to give 2-allylisoindoline-1,3-dione (11) (3.4 g, 18 mmol, 68% yield).  
2-Allylisoindoline-1,3-dione (11) (2.0 g, 11 mmol, 1 eq) was added in a sealed tube under nitrogen 
atmosphere to [RuCI2(PPh3)2] (0.10 g, 0.11 mmol, 0.01 eq). The solids were heated at 150 °C during 12 h 
and the reaction was cooled down to room temperature. The black mixture was dissolved in toluene and 
filtered on a celite pad. The solvents were evaporated and the brown orange solid was recrystallized in 
ethanol (20 mL). (E)-2-(prop-1-en-1-yl)isoindoline-1,3-dione (12) (1.15 g, 6.10 mmol, 58% yield) was 
collected as a yellow solid from the first recrystallization. 
1H NMR (400 MHz, CDCl3) δ 7.86 (dd, 2 H, J = 5.2, 3.1 Hz, Phth), 7.72 (dd, 2 H, J = 5.2, 3.0 Hz, Phth), 
6.64-6.54 (m, 2 H, CH=CH), 1.85 (d, 3 H, J = 5.1 Hz, CH3). 
1H NMR data match literature report.2  
(E)-2-Styrylisoindoline-1,3-dione (14) 
 
Following a reported procedure,3 a mixture of phenyl iodide (816 mg, 4.00 mmol, 1 eq), N-
vinylphthalimide (13) (693 mg, 4.00 mmol, 1 eq), Cy2NMe (1.17 g, 6.00 mmol, 1.5 eq), TBAB (1.29 g, 
4.00 mmol, 1 eq) and palladium acetate (1.00 mg, 4.00 µmol, 0.001 eq) in DMF (8 mL) was heated at 120 
°C (oil bath temperature) in a pressure tube after 5 cycles of vacuum/N2. After 1.5 h, the yellow solution 
was poured into toluene (40 mL) and rinsed with toluene (10 mL). This solution was filtered through a pad 
of celite and concentrated under vacuum. To the yellow oil was added ethanol (20 mL). The precipitated 
solid was recovered by filtration and rinsed with ethanol. (E)-2-styrylisoindoline-1,3-dione (14) (700 mg, 
2.77 mmol, 69% yield) was obtained as a yellow powder. 
1H NMR (400 MHz, CDCl3) δ 7.91 (dd, 2 H, J = 5.5, 3.1 Hz, Phth), 7.77 (dd, 2 H, J = 5.4, 3.1 Hz, Phth), 
7.66 (d, 1 H, J = 15.2 Hz, CH=CH), 7.51-7.45 (m, 2 H, ArH), 7.40-7.32 (m, 3 H, ArH), 7.30-7.24 (m, 1 H, 
CH=CH). 
Data match literature report.3 
                                                          
2 Stojanovic, A.; Renaud, P.; Schenk, K. Helv. Chim. Acta, 2004, 81, 268. 
3 Alacid, E.; Nájera, C. Adv. Synth. Catal. 2008, 350, 1316. 
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1-Vinylthymine (16). 
 
Following the described procedure of Racine et al.4, thymine (15) (0.50 g, 3.9 mmol, 1.0 eq), 
diacetoxypalladium (0.036 g, 0.16 mmol, 0.04 eq) were suspended in DMF (10 mL) in a flame-dried 
sealed microwave vial under nitrogen atmosphere. Vinyl acetate (0.82 g, 9.5 mmol, and 2.4 eq), 
triethylamine (1.3 mL, 9.5 mmol, 2.4 eq) and TMSOTf (1.7 mL, 9.5 mmol, and 2.4 eq) were added to the 
reaction mixture and stirred at 70 °C for 24 hours. The reaction mixture was cooled down to room 
temperature and the solvent was removed under reduced pressure. The crude mixture was purified by 
column chromatography, eluting with a mixture of ethyl acetate/ pentane (7:3). The pure 1-vinylthymine 
(16) (0.44 g, 2.8 mmol, 73% yield) was obtained as white solid. 
Rf 0.32 (3:7 Pentane/Ethyl acetate). 
1H NMR (400 MHz, Chloroform-d) δ 8.52 (s, 1 H, NH), 7.34 (d, J = 1.3 Hz, 1 H, thymine C=C-H), 7.20 
(dd, J = 16.0, 9.1 Hz, 1 H, vinyl-CH), 5.07 (dd, J = 16.0, 2.2 Hz, 1 H, vinyl-CH2), 4.92 (dd, J = 9.1, 2.2 
Hz, 1 H, vinyl-CH2), 1.99 (d, J = 1.3 Hz, 3 H, thymine-CH3). 
13C NMR (101 MHz, Chloroform-d) δ 163.4, 149.2, 134.6, 129.7, 112.2, 100.7, 12.7. 
NMR values correspond to the literature.4 
1-Vinylfluorouracil (18) 
 
Following the described procedure of Racine et al.,4 fluorouracil (17) (0.52 g, 3.9 mmol, 1.0 eq) and 
diacetoxypalladium (0.036 g, 0.16 mmol, 0.04 eq) were suspended in DMF (10 mL) in a flame-dried 
sealed microwave vial under nitrogen atmosphere. Vinyl acetate (0.82 g, 9.5 mmol, 2.4 eq), triethylamine 
(1.3 mL, 9.5 mmol, 2.4 eq) and TMSOTf (1.7 mL, 9.5 mmol, 2.4 eq) were added to the reaction mixture 
and stirred at 70°C for 24 hours. The reaction mixture was cooled down to room temperature and the 
solvent was removed under reduced pressure. The crude mixture was purified by column chromatography, 
eluting with a mixture of ethyl acetate/ pentane (5:5). The pure 1-vinylfluorouracil (18) (0.31 g, 2.0 mmol, 
50% yield) was obtained as white solid. 
Rf  0.35 (6:4 Pentane/Ethyl acetate). 
1H NMR (400 MHz, DMSO-d6) δ 12.01 (s, 1H, N H), 8.43 (d, J = 7.1 Hz, 1 H, F-uracil C=C-H), 7.07 
(ddd, J = 16.0, 9.2, 1.9 Hz, 1 H, vinyl-CH), 5.36 (dd, J = 15.9, 2.0 Hz, 1 H, vinyl-CH2), 4.88 (dd, J = 9.2, 
2.0 Hz, 1 H, vinyl-CH2). 
                                                          
4 Racine, S.; de Nanteuil, F.; Serrano, E.; Waser, J. Angew. Chem. Int. Ed. 2014, 53, 8484–8487. 
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1H NMR values are in accordance with the spectra performed in chloroform in the literature.4 
Dimethyl 2-methylenemalonate (20) 
 
Following the described procedure of De Nanteuil et al.,5 paraformaldehyde (2.7 g, 90 mmol, 2.0 eq) and 
diisopropylamine 2,2,2-trifluoroacetate (9.7 g, 45 mmol, 1.0 eq) were added in a flame dried 250 mL 
round flask with a condenser. Then, tetrahydrofuran (65 mL), dimethyl malonate (19) (5.1 mL, 45 mmol, 
1.0 eq) and trifluoroacetic acid (0.35 mL, 4.5 mmol, 0.1 eq) were added into the flask under nitrogen 
atmosphere and the suspension was stirred to reflux for 2 hours. Paraformaldehyde (2.7 g, 90 mmol, 2.0 
eq) was added to the reaction mixture and the reflux was restarted for 12 hours. The reaction mixture was 
cooled to room temperature and THF was removed under reduced pressure. The crude product was 
dissolved in diethyl ether (25 mL) and filtrated trough cotton. The organic layer was washed two times 
with 1 M HCl (25 mL), the aqueous layers were combined and washed three times with diethyl ether (50 
mL). The combined organic layers were dry over magnesium sulfate, filtrated and concentrated under 
reduced pressure. The crude mixture containing 20 was obtained as colorless oil (2.5 g). 
1H NMR (400 MHz, Chloroform-d) δ 6.58 (s, 2 H, CH2), 3.83 (s, 6 H, ester CH3). 
1H NMR values correspond to the literature.5 
 
2.2 Synthesis of Cyclobutanes 
Dimethyl 2-(1,3-dioxoisoindolin-2-yl)cyclobutane-1,1-dicarboxylate (4a) 
 
Following a reported procedure,5  dimethyl malonate (19) (1.32 mL, 11.6 mmol, 2 eq), diisopropylamine 
2,2,2-trifluoroacetate (2.49 g, 11.6 mmol, 2 eq), paraformaldehyde (0.695 mg, 23.1 mmol, 4 eq) and 
trifluoroacetic acid (89.0 µL, 1.16 mmol, 0.2 eq) were added to tetrahydrofuran (20 mL). A condenser was 
added and the suspension was stirred at reflux for 2 h. Paraformaldehyde (0.695 mg, 23.1 mmol, 4 eq) was 
added and the reflux was continued for 6 h. The reaction was cooled to room temperature and the 
tetrahydrofuran was removed under reduced pressure (300 to 50 mbar at 45°C). The crude was dissolved 
in diethyl ether (25 mL) and filtered through cotton in a separatory funnel. The organic layer was washed 
twice with 1 M HCl (25 mL). The aqueous layers were combined and extracted with diethyl ether (25 
mL). The organic layers were combined, dried over anhydrous Na2SO4, filtered and concentrated under 
reduced pressure to give dimethyl 2-methylenemalonate crude (20) as colorless oil.  
                                                          
5 De Nanteuil, F.; Waser, J. Angew. Chem. Int. Ed. 2013, 52, 9009–9013. 
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The iron trichloride supported on alumina (1.00 mmol/g, 289 mg, 0.289 mmol, 0.05 eq) was weighted in 
an oven-dry flask in a glovebox. The flask was closed with a silicon septum, taken out of the glovebox and 
put under positive pressure of nitrogen and dichloromethane (5 mL) was added. 2-vinylisoindoline-1,3-
dione (13) (1.00 g, 5.77 mmol, 1 eq) was dissolved in dichloromethane (5 mL) and added to the yellow 
suspension. Finally, the crude dimethyl 2-methylenemalonate (20) was dissolved in dichloromethane (5 
mL) and added to the reaction in one portion. The reaction was stirred at room temperature for 16 h and 
then filtered over a basic alumina plug, eluting with ethyl acetate. The solvents were evaporated and the 
brown solid was purified by column chromatography on Biotage (SNAP cartridge KP-SIL 50 g, 95:5 to 
4:6 Hexane/Ethyl acetate) affording cyclobutane 4a (1.55 g, 4.89 mmol, 85% yield) as a colorless solid. 
Rf 0.45 (1:1 Hexane/Ethyl acetate). 
1H NMR (400 MHz, CDCl3) δ 7.93 (m, 2 H, Phth), 7.80 (m, 2 H, Phth), 5.17 (t, 1 H, J = 10.9 Hz, N-C-H), 
3.16 (s, 3 H, CO2CH3), 2.98 (s, 3 H, CO2CH3), 2.58 (m, 1 H, CH2), 2.25 (m, 1 H, CH2), 1.48 (m, 1 H, 
CH2), 1.33 (dt, 1 H, J = 13.6, 10.4 Hz, CH2). 
13C NMR (101 MHz, CDCl3) δ 170.6, 168.7, 168.3, 134.3, 131.9, 123.5, 59.0, 53.2, 53.0, 47.9, 24.7, 21.9. 
Data match literature report.5  
 
Dimethyl 2-(1,3-dioxoisoindolin-2-yl)-3-methylcyclobutane-1,1-dicarboxylate (4b) 
 
Following a reported procedure,5 dimethyl malonate (19) (1.22 mL, 10.7 mmol, 2 eq), diisopropylamine 
2,2,2-trifluoroacetate (2.30 g, 10.7 mmol, 2 eq), paraformaldehyde (0.640 mg, 21.4 mmol, 4 eq) and 
trifluoroacetic acid (82.0 µl, 1.07 mmol, 0.2 eq) were added to tetrahydrofuran (20 mL). A condenser was 
added and the suspension was stirred at reflux for 2 h. Paraformaldehyde (0.640 mg, 21.4 mmol) was 
added and the reflux was continued for 6 h. The reaction was cooled to room temperature and the 
tetrahydrofuran was removed under reduced pressure. The crude was dissolved in diethyl ether (25 mL) 
and filtered through cotton in a separatory funnel. The organic layer was washed twice with 1 M HCl (25 
mL). The aqueous layers were combined and extracted with diethyl ether (25 mL). The organic layers 
were combined, dried over anhydrous Na2SO4, filtered and concentrated under reduced pressure to give 
dimethyl 2-methylenemalonate crude as colorless oil.  
The iron trichloride supported on alumina (1.00 mmol/g, 267 mg, 0.267 mmol, 0.05 eq) was weighted in 
an oven-dry flask in a glovebox. The flask was closed with a silicon septum, taken out of the glovebox and 
put under a positive pressure of nitrogen. Dichloromethane (5 mL) was added. The reaction was cooled to 
0 °C and (E)-2-(prop-1-en-1-yl)isoindoline-1,3-dione (12) (1.00 g, 5.34 mmol, 1 eq) was dissolved in 
dichloromethane (5 mL) and added to the yellow suspension dropwise. Finally, the crude dimethyl 2-
methylenemalonate was dissolved in dichloromethane (5 mL) and added to the reaction mixture dropwise. 
The reaction mixture was stirred at room temperature for 4 h and then filtered over a basic alumina plug, 
eluting with ethyl acetate. The solvents were evaporated and the brown solid was purified by column 
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chromatography on Biotage (SNAP cartridge KP-SIL 50 g, 95:5 to 4:6 Hexane/Ethyl acetate) affording 
cyclobutane 4b (1.53 g, 4.62 mmol, 86% yield) as a colorless solid. 
Rf 0.26 (7:3 Hexane/Ethyl acetate). 
Mp 112.1-114.3 °C. 
1H NMR (400 MHz, CDCl3) δ 7.83 (m, 2 H, Phth), 7.72 (m, 2 H, Phth), 4.96 (d, 1 H, J = 10.3 Hz, N-C-
H), 3.71 (m, 4 H, CO2CH3 and C-H-CH3), 3.60 (s, 3 H, CO2CH3), 3.00 (dd, 1H, J = 10.9, 9.3 Hz, CH2), 
1.74 (dd, 1 H, J = 11.5, 9.5 Hz, CH2), 1.16 (d, 3 H, J = 6.6 Hz, CH3). 
13C NMR (101 MHz, CDCl3) δ 170.4, 168.6, 168.3, 134.2, 131.8, 123.4, 56.3, 54.9, 53.0, 52.9, 32.1, 29.9, 
19.3. 
Data match literature report.5  
Dimethyl 2-(1,3-dioxoisoindolin-2-yl)-3-phenylcyclobutane-1,1-dicarboxylate (4c) 
 
Following a slightly modified procedure,5 in the glovebox, iron trichloride supported on alumina (1.00 
mmol/g, 282 mg, 0.282 mmol, 0.05 eq) was added to a microwave vial. The vial was sealed with a Teflon 
septum and taken out of the glovebox. Dry dichloromethane (5 mL) was added and (E)-2-
styrylisoindoline-1,3-dione (14) (1.41 g, 5.64 mmol, 1 eq) was dissolved in dry dichloromethane (5 mL) 
and added to the iron trichloride. Dimethyl 2-methylenemalonate (20) (1.63 g, 11.3 mmol, 2 eq) was 
dissolved in dry dichloromethane (5 mL) and added dropwise over 2 h. When the addition was finished, 
the reaction was stirred for 4 h at room temperature. Then, dimethyl 2-methylenemalonate (406 mg, 2.82 
mmol, 0.5 eq) was dissolved in dry dichloromethane (2 mL) and added in one portion. The reaction was 
stirred at reflux for 2 h, and then filtered over a pad of alumina, eluted with ethyl acetate and concentrated 
under vacuum. The crude product was purified by column chromatography (SiO2, 9:1 to 7:3 Pentane/Ethyl 
Acetate) affording cyclobutane 4c (1.74 g, 4.42 mmol, 78% yield) as a colorless oil. 
Rf 0.28 (7:3 Hexane/Ethyl acetate). 
1H NMR (400 MHz, CDCl3) δ 7.63 (dd, 2 H, J = 3.7, 2.1 Hz, Phth), 7.55 (dd, 2 H, J = 3.8, 2.1 Hz, Phth), 
7.29-7.24 (m, 4 H, Ph), 7.23-7.19 (m, 1 H, Ph), 5.52 (dd, 1 H, J = 7.4, 0.4 Hz, N-C-H), 4.86-4.96 (m, 1 H, 
H-C-Ph), 3.76 (s, 3 H, CO2CH3), 3.65 (s, 3 H, CO2CH3), 3.25 (ddd, 1 H, J = 7.7, 6.5, 0.4 Hz, CH2), 2.21 
(dd, 1 H, J = 7.8, 6.9 Hz, CH2). 
13C NMR (101 MHz, CDCl3) δ 158.8, 157.4, 157.2, 134.0, 128.8, 126.6, 124.1, 122.9, 122.5, 119.7, 63.1, 
61.4, 60.7, 60.7, 48.4, 42.9. 
Data match literature report.5  
 
Diethyl 2-(1,3-dioxoisoindolin-2-yl)-4-methylcyclobutane-1,1-dicarboxylate (4d) 
 
Following a slightly modified procedure,5 in the glovebox, iron trichloride supported on alumina (1.00 
mmol/g, 289 mg, 0.289 mmol, 0.1 eq) was added to a microwave vial. The vial was sealed with a Teflon 
septum and taken out of the glovebox. Dry dichloromethane (3 mL) was added. Diethyl 2-
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ethylidenemalonate (21) (1.07 g, 5.77 mmol, 2 eq) and 2-vinylisoindoline-1,3-dione (13) (500 mg, 2.89 
mmol, 1 eq) were dissolved in dry dichloromethane (4 mL). The solution was then added dropwise to the 
iron trichloride. The reaction was stirred at 40 °C for 16 h. Then the reaction was filtered over a pad of 
alumina, eluted with ethyl acetate and concentrated under vacuum. The crude product was purified by 
column chromatography (SiO2, 8:2 Pentane/Ethyl Acetate), affording cyclobutane 4d (806 mg, 2.24 
mmol, 78 % yield, 1.1:1 dr determined by integration of the peaks at 5.58 (maj) and 4.91 (min) in the 
crude 1H NMR, as a pale yellow oil. 
Rf 0.25 (7:3 Hexane/Ethyl acetate). 
1H NMR (400 MHz, CDCl3) on a 1.1(maj):1(min) mixture δ 7.84-7.79 (m, 3.8 H, Phth maj + min), 7.72-
7.67 (m, 3.8 H, Phth maj + min), 5.58 (ddd, J = 10.0, 8.3, 1.2 Hz, 1 H, N-C-H min), 4.91 (dd, J = 10.9, 8.7 
Hz, 0.9 H, N-C-H min), 4.27-4.18 (m, 3.8 H, CO2CH2 maj + min), 4.17- 3.91 (m, 3.8 H, CO2CH2 maj + 
min), 3.65-3.54 (m, 1 H, CH cyclobutane maj), 3.27-3.12 (m, 1.9 H, CH2 cyclobutane maj + min), 2.78 
(ddq, J = 10.7, 8.1, 7.0 Hz, 0.9 H, CH cyclobutane min), 2.46 (dt, J = 10.8, 8.5 Hz, 0.9 H, CH2 cyclobutane 
min), 1.98 (ddd, J = 11.7, 10.0, 5.4 Hz, 1 H, CH2 cyclobutane maj), 1.32 (d, J = 7.0 Hz, 2.7 H, CH3 min), 
1.28-1.21 (m, 5.7 H, CO2CH2CH3 maj + min), 1.14 (d, J = 7.3 Hz, 3 H, CH3 maj), 1.05 (t, J = 7.1 Hz, 2.7 
H, CO2CH2CH3 min), 0.90 (t, J = 7.1 Hz, 3 H, CO2CH2CH3 maj). 
13C NMR (101 MHz, CDCl3) δ 170.2, 168.5, 168.4, 168.3, 168.1, 167.5, 134.1, 134.0, 132.0, 131.8, 
123.3, 123.2, 62.4, 62.0, 61.7,6 61.6, 60.9, 47.5, 45.1, 33.8, 31.1, 29.6, 28.7, 16.5, 16.2, 14.2, 14.0, 13.9, 
13.6. 
Data match literature report.5 
 
Dimethyl 2-(5-methyl-2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl)cyclobutane-1,1-dicarboxylate (22) 
 
Following an adapted described procedure of De Nanteuil et al.,5 5-methyl-1-vinylpyrimidine-2,4(1H,3H)-
dione (16) (0.43 g, 2.9 mmol, 1.0 eq) and iron trichloride supported on alumina (1.0 mmol/g, 0.57 g, 0.57 
mmol, 0.2 eq) were added in a flame dried microwave vial under nitrogen atmosphere. Then, dry 
dichloromethane (7 mL) and a solution of crude freshly prepared dimethyl 2-methylenemalonate (20) 
(0.82 g, 5.7 mmol, 2.0 eq) in dichloromethane (3 mL) were added into the vial and the reaction mixture 
was stirred at room temperature for 14 hours. The reaction mixture was filtrated over a pad of alumina 
eluting with ethyl acetate (25 mL) and concentrated under reduced pressure. The crude mixture was 
purified via column chromatography, eluting with a mixture of ethyl acetate/ pentane (6:4 to 9:1). The 
pure product 22 (0.36 g, 1.2 mmol, 43% yield) was obtained as a white solid. 
Rf  0.21 (2 :8 Pentane/Ethyl acetate). 
Mp 180.4- 182.1°C. 
1H NMR (400 MHz, Chloroform-d) δ 7.99 (s, 1 H, NH), 7.05 (d, J = 1.3 Hz, 1 H, thymine C=C-H), 5.33 
(t, J = 9.2 Hz, 1 H, cyclobutane-CH), 3.77 (s, 3 H, ester CH3), 3.69 (s, 3 H, ester CH3), 2.79 – 2.67 (m, 2 
H, cyclobutane-CH2), 2.35 (q, J = 8.5 Hz, 1 H, cyclobutane-CH2), 2.27 – 2.16 (m, 1 H, cyclobutane-CH2), 
1.93 (d, J = 1.2 Hz, 3 H, thymine-CH3).  
                                                          
6 Two peaks under this signal as determined by HMBC. 
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13C NMR (101 MHz, Chloroform-d) δ 170.0, 168.8, 163.9, 151.0, 137.7, 110.3, 59.1, 55.0, 53.2, 53.1, 
23.7, 22.8, 12.5.  
IR 3190 (w), 3034 (w), 2958 (w), 2361 (m), 1733 (s), 1690 (s), 1439 (w), 1278 (m), 1113 (w), 915 (w), 
735 (w).  
HRMS (ESI) calcd for C13H16N2NaO6+ [M+Na]+ 319.0901, found 319.0904. 
Dimethyl 2-(3-benzoyl-5-methyl-2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl)cyclobutane-1,1-
dicarboxylate (4e). 
 
Following an adapted described procedure of Racine et al.,4 in a flame dried microwave vial under 
nitrogen atmosphere, cyclobutane 22 (0.32 g, 1.1 mmol, 1.0 eq) and dimethyl-4-aminopyridine (0.13 g, 
1.1 mmol, 1.0 eq) were dissolved in dry dichloromethane (10 mL). Then, triethylamine (0.60 mL, 4.3 
mmol, 4.0 eq) was added and the solution was cooled to 0 °C. Benzoyl chloride (0.38 mL, 3.2 mmol, 3.0 
eq) was added dropwise and the reaction mixture was stirred at room temperature for 14 hours. A 
saturated solution of NaHCO3 (8 mL) was added to the reaction mixture and the layers were separated. 
The aqueous layer was extracted with dichloromethane (2 x 20 mL). The combined organic layers were 
washed with 1 M HCl (2 x 40 mL) and with water (30 mL), dried over MgSO4 and concentrated under 
reduced pressure. The crude product was purified by column chromatography, eluting with a mixture of 
pentane/ ethyl acetate (4:6 to 2:8). The pure product 4e (0.37 g, 0.93 mmol, 86% yield) was obtained as 
colorless foam. 
Rf  0.32 (4:6 Pentane/Ethyl acetate). 
Mp 153.8-155.4°C. 
1H NMR (400 MHz, Chloroform-d) δ 7.96 – 7.90 (m, 2 H, Ar-H), 7.65 – 7.59 (m, 1 H, Ar-H), 7.50 – 7.44 
(m, 2 H, Ar-H), 7.16 (d, J = 1.2 Hz, 1 H, thymine C=C-H), 5.17 (t, J = 9.5 Hz, 1 H, cyclobutane-CH), 3.69 
(s, 3 H, ester CH3), 3.66 (s, 3 H, ester CH3), 2.94 – 2.82 (m, 1 H, cyclobutane-CH2), 2.74 (td, J = 11.0, 3.1 
Hz, 1 H, cyclobutane-CH2), 2.35 (dtd, J = 11.6, 8.8, 3.1 Hz, 1 H, cyclobutane-CH2), 2.18 (dt, J = 11.7, 8.9 
Hz, 1 H, cyclobutane-CH2), 1.95 (d, J = 1.2 Hz, 3 H, thymine-CH3).  
13C NMR (101 MHz, Chloroform-d) δ 170.2, 168.9, 168.7, 162.8, 150.1, 138.7, 135.0, 131.6, 130.7, 
129.1, 110.4, 58.8, 56.9, 53.3, 53.2, 23.9, 22.7, 12.6.  
IR 3006 (w), 2959 (w), 2358 (w), 2257 (w), 1737 (s), 1702 (m), 1655 (s), 1438 (m), 1266 (s), 1107 (m), 
984 (w), 914 (w), 733 (s).  
HRMS (ESI) calcd for C20H20N2NaO7+ [M+Na]+ 423.1163; found 423.1168. 
Dimethyl 2-(5-fluoro-2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl)cyclobutane-1,1-dicarboxylate (23) 
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Following an adapted described procedure of De Nanteuil et al.,5 5-fluoro-1-vinylpyrimidine-2,4(1H,3H)-
dione (18) (0.60 g, 3.8 mmol, 1.0 eq) and iron trichloride supported on alumina (1.0 mmol/g, 0.77 g, 0.77 
mmol, 0.2 eq) were added in a flame dried microwave vial under nitrogen atmosphere. Then, dry 
dichloromethane (8 mL) and a solution of crude freshly prepared dimethyl 2-methylenemalonate (20) (2.2 
g, 15 mmol, 4.0 eq) in dichloromethane (2 mL) were added into the vial and the reaction mixture was 
stirred at room temperature for 14 hours. The reaction mixture was filtrated over a pad of alumina eluting 
with ethyl acetate (50 mL) and concentrated under reduced pressure. The crude mixture was purified via 
column chromatography, eluting with a mixture of ethyl acetate/ pentane (5:5 to 2:8). The pure product 23 
(0.78 g, 2.6 mmol, 67% yield) was obtained as a colorless oil. 
Rf  0.28 (4:6 Pentane/Ethyl acetate). 
1H NMR (400 MHz, Chloroform-d) δ 9.54 (s, 1 H, NH), 7.36 (d, J = 6.1 Hz, 1 H, F-uracil C=C-H), 5.28 
(t, J = 9.0 Hz, 1 H, cyclobutane-CH), 3.78 (s, 3 H, ester CH3), 3.73 (s, 3 H, ester CH3), 2.68 – 2.61 (m, 2 
H, cyclobutane-CH2), 2.41 – 2.32 (m, 1 H, cyclobutane-CH2), 2.32 – 2.25 (m, 1 H, cyclobutane-CH2).  
13C NMR (101 MHz, Chloroform-d) δ 169.7, 168.8, 156.8 (d, J = 26.7 Hz), 149.7, 140.2 (d, J = 237.5 
Hz), 126.3 (d, J = 33.7 Hz), 59.0, 55.2, 53.3, 53.3, 23.7, 23.0.  
IR 3211 (w), 3085 (w), 2960 (w), 2362 (w), 2336 (w), 1726 (s), 1439 (w), 1361 (w), 1273 (m), 1110 (w), 
915 (w), 735 (m).  
HRMS (ESI) calcd for C12H13FN2NaO6+ [M+Na]+ 323.0650; found 323.0654. 
Dimethyl 2-(3-benzoyl-5-fluoro-2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl)cyclobutane-1,1-
dicarboxylate (4f) 
 
Following an adapted described procedure of Racine et al.,4 in a flame dried microwave vial under 
nitrogen atmosphere, 23 (0.70 g, 2.3 mmol, 1.0 eq) and dimethyl-4-aminopyridine (0.28 g, 2.3 mmol, 1.0 
eq) were dissolved in dry dichloromethane (12 mL). Triethylamine (1.3 mL, 9.3 mmol, 4.0 eq) was added 
and the solution was cooled to 0°C. Then, benzoyl chloride (0.81 mL, 6.9 mmol, 3.0 eq) was added 
dropwise and the reaction mixture was stirred at room temperature for 16 hours. A saturated solution of 
NaHCO3 (8 mL) was added to the reaction mixture and the layer were separated. The aqueous layer was 
extracted with dichloromethane (2 x 20 mL). The combined organic layers were washed with 1 M HCl (2 
x 40 mL) and with water (30 mL), dried over MgSO4 and concentrated under reduced pressure. The pure 
product 4f (0.61 g, 1.5 mmol, 65%) was obtained as colorless foam. 
Rf  0.55 (4:6 Pentane/Ethyl acetate). 
Mp 60.9- 62.5°C. 
1H NMR (400 MHz, Chloroform-d) δ 7.93 – 7.89 (m, 2 H, Ar-H), 7.66 – 7.59 (m, 1 H, Ar-H), 7.50 – 7.43 
(m, 3 H, Ar-H and F-uracil C=C-H), 5.12 (t, J = 9.4 Hz, 1 H, cyclobutane-CH), 3.69 (s, 3 H, ester CH3), 
3.64 (s, 3 H, ester CH3), 2.73 (q, J = 10.0 Hz, 1 H, cyclobutane-CH2), 2.66 – 2.58 (m, 1 H, cyclobutane-
CH2), 2.33 (dtd, J = 10.6, 8.4, 2.4 Hz, 1 H, cyclobutane-CH2), 2.23 (dt, J = 11.6, 8.9 Hz, 1 H, cyclobutane-
CH2).  
13C NMR (101 MHz, Chloroform-d) δ 169.8, 168.7, 167.1, 156.3 (d, J = 27.1 Hz), 148.6, 139.8 (d, J = 
239.4 Hz), 135.5, 131.0, 130.9, 129.3, 127.1 (d, J = 33.6 Hz), 58.7, 56.8, 53.4, 53.3, 23.9, 22.8.  
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IR 3090 (w), 3009 (w), 2958 (w), 2361 (w), 2262 (w), 1723 (s), 1668 (s), 1598 (w), 1445 (m), 1357 (w), 
1266 (s), 1106 (m), 982 (w), 912 (m), 851 (w), 732 (s).  
HRMS (ESI) calcd for C19H17N2FNaO7+ [M+Na]+ 427.0917; found 427.0920. 
 
2.3 Synthesis of Enol Ethers 
General procedure for the synthesis of TBS enol ethers (GP1) 
 
Ketone 24 (1 eq) is dissolved in dry THF (20 mL) under nitrogen atmosphere and cooled down to 0 °C. 
NaHMDS (1.2 eq, 1.9 M in THF) is added dropwise. The orange solution is stirred at room temperature 
for 1 hour and then cooled to 0 °C. The chlorosilane (1.2 eq) is dissolved in THF (3 mL) and added 
dropwise. The reaction is stirred at room temperature for 2 hours and then concentrated under reduced 
pressure. The crude oil is filtered through a silica plug, eluting with 250 mL hexanes, concentrated under 
reduced pressure and purified by bulb to bulb distillation. 
Tert-butyldimethyl((1-phenylvinyl)oxy)silane (7a) 
 
Acetophenone (24a) (580 mg, 4.82 mmol, 1 eq) in anhydrous THF (5 mL) is added in an oven-dried flask 
sealed with a septum and under N2 atmosphere. The solution is cooled down to -78 °C and a 2 M solution 
of NaHMDS (2.94 mL, 5.88 mmol, 1.22 eq) is added dropwise. The cold bath is removed and the pale 
yellow solution is stirred for 1 hour at room temperature. The reaction is cooled again at -78 °C and tert-
butylchlorodimethylsilane (871 mg, 5.78 mmol, 1.2 eq) is added dropwise. The reaction is stirred at room 
temperature for 5 hours after what the solvent is directly removed under reduced pressure. The resulting 
orange oil is purified by column chromatography on triethylamine-deactivated silica (100 % Hexane). 
Tert-butyldimethyl((1-phenylvinyl)oxy)silane (7a) (960 mg, 4.10 mmol, 85% yield) is obtained as a 
colorless oil which can be re-purified by short path distillation in case of degradation with time. 
1H NMR (400 MHz, CDCl3) δ 7.65-7.60 (m, 2 H, Ar), 7.39-7.29 (m, 3 H, Ar), 4.89 (d, 1 H, J = 1.7 Hz, 
C=CH2), 4.42 (d, 1 H, J = 1.7 Hz, C=CH2), 1.00 (s, 9 H, Si(CH3)2C(CH3)3), 0.21 (s, 6 H, 
Si(CH3)2C(CH3)3).  
13C NMR (101 MHz, CDCl3) δ 156.0, 137.8, 128.2, 128.1, 125.3, 90.9, 25.9, 18.4, -4.6. 
Data match literature report.7 
Tert-butyl(1-(4-methoxyphenyl)vinyl)oxy)dimethylsilane (7b) 
                                                          
7 J.-F. Zhao, B.-H. Tan, T.-P. Loh Chem. Sci. 2011, 2, 349. 
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Following GP1, 1-(4-methoxyphenyl)ethanone (24b) (2.0 g, 13 mmol, 1 eq), NaHMDS (8.4 mL, 16 
mmol, 1.2 eq and tert-butylchlorodimethylsilane (2.4 g, 16 mmol, 1.2 eq) were reacted. Tert-butyl(1-(4-
methoxyphenyl)vinyl)oxy)dimethylsilane (7b) (2.5 g, 9.5 mmol, 71%) was obtained as a colorless oil. 
1H NMR (400 MHz, DMSO-d6) δ 7.54 (d, J = 8.9 Hz, 2 H, Ar), 6.93 (d, J = 8.9 Hz, 2 H, Ar), 4.89 (d, J = 
1.8 Hz, 1 H, CH2 vinyl), 4.32 (d, J = 1.8 Hz, 1 H, CH2 vinyl), 3.77 (s, 3 H, OMe), 0.98 (s, 9 H, OTBS), 
0.20 (s, 6 H, OTBS).  
13C NMR (101 MHz, DMSO) δ 159.4, 154.7, 129.5, 126.2, 113.5, 89.4, 55.1, 25.7, 18.0, -4.7. 
NMR data of 7b corresponded to the reported spectra.8 
Tert-butyl(1-(4-fluorophenyl)vinyl)oxy)dimethylsilane (7c) 
 
Following GP1, 1-(4-fluorophenyl)ethanone (24c) (2.0 g, 15 mmol, 1 eq), NaHMDS (9.1 mL, 17 mmol, 
1.2 eq and tert-butylchlorodimethylsilane (2.6 g, 17 mmol, 1.2 eq) were reacted. Tert-butyl(1-(4-
fluorophenyl)vinyl)oxy)dimethylsilane (7c) (0.80 g, 3.2 mmol, 22%) was obtained as a colorless oil. 
1H NMR (400 MHz, DMSO-d6) δ 7.65 (dd, J = 9.0, 5.5 Hz, 2 H, Ar), 7.21 (t, J = 8.9 Hz, 2 H, Ar), 5.00 
(d, J = 2.1 Hz, 1 H, CH2 vinyl), 4.43 (d, J = 2.0 Hz, 1 H, CH2 vinyl), 0.98 (d, J = 0.8 Hz, 9 H, OTBS), 
0.21 (d, J = 0.9 Hz, 6 H, OTBS).  
13C NMR (101 MHz, DMSO) δ 162.1 (d, J = 245.5 Hz), 153.9, 133.5 (d, J = 3.2 Hz), 126.9 (d, J = 8.4 
Hz), 115.1 (d, J = 21.6 Hz), 91.1, 25.6, 17.9, -4.8.  
IR 2891 (w), 2866 (w), 2821 (w), 2788 (w), 1564 (w), 1470 (w), 1456 (m), 1456 (m), 1351 (m), 1311 (w), 
1144 (s), 1144 (s), 1122 (s), 1085 (m), 1060 (s), 1060 (s), 823 (s).  
HRMS (ESI) calcd for C14FH21KOSi+ [M+K]+ 291.0977; found 291.1180. 
Methyl 4-(1-(tert-butyldimethylsilyl)oxy)vinyl)benzoate (7d) 
 
Following GP1, methyl 4-acetylbenzoate (24d) (1.0 g, 5.6 mmol, 1 eq), NaHMDS (3.5 mL, 6.7 mmol, 1.2 
eq and tert-butylchlorodimethylsilane (1.0 g, 6.7 mmol, 1.2 eq) were reacted. Methyl 4-(1-(tert-
butyldimethylsilyl)oxy)vinyl)benzoate (7d) (0.50 g, 1.7 mmol, 31%) was obtained as a colorless oil. 
1H NMR (400 MHz, DMSO-d6) δ 8.07 – 7.86 (m, 2 H, Ar), 7.86 – 7.68 (m, 2 H, Ar), 5.20 (d, J = 2.2 Hz, 
1 H, CH2 vinyl), 4.59 (d, J = 2.2 Hz, 1 H, CH2 vinyl), 3.86 (s, 3 H, OMe), 0.98 (s, 9 H, OTBS), 0.22 (s, 6 
H, OTBS).  
                                                          
8 Ventura, D. L.; Li, Z.; Coleman, M. G.; Davies, H. M. L. Tetrahedron 2009, 65, 3052. 
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13C NMR (101 MHz, DMSO) δ 165.8, 153.9, 141.4, 129.2, 125.0, 93.8, 52.1, 30.7, 25.6, 18.0, -4.8.  
IR 2888 (w), 2866 (w), 2821 (w), 2820 (w), 2787 (w), 1583 (s), 1464 (w), 1146 (m), 1106 (s), 937 (m), 
926 (m), 828 (m).  
HRMS (ESI) calcd for C16H25O3Si+ [M+H]+ 293.1567; found 293.1560. 
(Z)-Tert-butyldimethyl((1-phenylprop-1-en-1-yl)oxy)silane (7e) 
 
Following GP1, propiophenone (24e) (1.0 g, 7.5 mmol, 1 eq), NaHMDS (4.7 mL, 8.9 mmol, 1.2 eq) and 
tert-butylchlorodimethylsilane (1.3 g, 8.9 mmol, 1.2 eq) were reacted. (Z)-Tert-butyldimethyl((1-
phenylprop-1-en-1-yl)oxy)silane (7e) (0.51 g, 2.0 mmol, 27%) was obtained as a colorless oil, which was 
used directly in the [4+2] annulation step. 
 
3. Optimization of the [4+2] Annulation 
 
Optimization procedure for SnCl4 and TiCl4: 
Preparation of the SnCl4 solution: in an oven dried flask, under nitrogen atmosphere, SnCl4 (0.22 g, 0.10 
mL, 0.86 mmol) were added to dry dichloromethane (1.9 mL) to make a 0.43 M solution. 
Preparation of the TiCl4 solution: in an oven dried flask, under nitrogen atmosphere, TiCl4 (0.17 g, 0.10 
mL, 0.91 mmol) were added to dry dichloromethane (1.9 mL) to make a 0.46 M solution. 
The cyclobutane 4 (0.050 mmol, 1 eq) was dissolved in dry dichloromethane (1.0 mL), and added in an 
oven dried microwave vial under nitrogen atmosphere. The aldehyde 5a (0.075 mmol, 1.5 eq) was then 
dissolved in dry dichloromethane (0.50 mL) and added. The Lewis acid solution was then added dropwise 
to the reaction mixture. The reaction was quenched with triethylamine (0.10 mL), and concentrated under 
vacuum. The crude mixture was then dissolved in CDCl3 and analyzed by 1H NMR. 
 
Optimization procedure for other Lewis acids: 
In the glovebox, the Lewis acid was added to a microwave vial. The vial was sealed with a Teflon septum 
and taken out of the glovebox. Dry dichloromethane (0.50 mL) was added. The cyclobutane 4 (0.050 
mmol, 1 eq) was dissolved in dry dichloromethane (0.50 mL) and added. The aldehyde 5a (0.075 mmol, 
1.5 eq) was then dissolved in dry dichloromethane (0.50 mL) and added. The reaction was then filtered 
over a pad of alumina, eluted with ethyl acetate and concentrated under vacuum. The crude mixture was 
then dissolved in CDCl3 and analyzed by 1H NMR. 
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Entry Catalyst (mol%) Time T Solvent Conversiona drb R, R1, R2 
1 FeCl3·Al2O3 (20 mol%) 40 min rt DCM >95%c 2:1 H, H, Me 
2 SnCl4 (20 mol%) 2.5 h rt DCM >95%c 6:1 H, H, Me 
3 Hf(OTf)4 (20 mol%) 2.5 h rt DCM >95%c 9:1 H, H, Me 
4 Yb(OTf)3 (20 mol%) 2.5 h rt DCM <5%d - H, H, Me 
5 Sn(OTf)2 (20 mol%) 2.5 h rt DCM <5% - H, H, Me 
6 Cu(OTf)2 (20 mol%) 2.5 h rt DCM <5% - H, H, Me 
7 AuCl (20 mol%) 2.5 h rt DCM <5% - H, H, Me 
8 AuCl3 (20 mol%) 2.5 h rt DCM >95%e - H, H, Me 
9 TiCl4 (20 mol%) 2.5 h rt DCM 88%c 5:1 H, H, Me 
10 In(OTf)3 (20 mol%) 2.5 h rt DCM >95% 9:1 H, H, Me 
11 Sc(OTf)3 (20 mol%) 2.5 h rt DCM >95% 13:1 H, H, Me 
12 Sc(OTf)3 (20 mol%) 7 h reflux DCM <5%d - Me, H, Me 
13 In(OTf)3 (20 mol%) 18 h reflux DCM 34% 4.5:1
:1 
Me, H, Me 
14 FeCl3 (100 mol%) 18 h  rt DCM >95% 6:1:1
f 
Me, H, Me 
15 SnCl4 (20 mol%) 2.5 h rt DCM <5%d - Me, H, Me 
16 SnCl4 (100 mol%) 2.5 h -40 °C DCM >95%e - Me, H, Me 
17 FeCl3·SiO2 (100 mol%) 18 h rt DCM >95%c  - Me, H, Me 
18 FeBr3 (100 mol%) 18 h rt DCM >95%c - Me, H, Me 
19 FeCl3·Al2O3 (100 mol%) 2.5 h rt ACN <5%d - Me, H, Me 
20 FeCl3·Al2O3 (100 mol%) 2.5 h rt MeOH <5%d - Me, H, Me 
21 FeCl3·Al2O3 (100 mol%) 2.5 h rt DMF <5%d - Me, H, Me 
22 FeCl3·Al2O3 (100 mol%) 2.5 h rt THF <5%d - Me, H, Me 
23 FeCl3·Al2O3 (100 mol%) 18 h rt Toluene 76%c - Me, H, Me 
24 FeCl3·Al2O3 (100 mol%)g 5 h  rt DCM >95%e - Me, H, Me 
25 FeCl3·Al2O3 (100 mol%) 5 h rt DCM >95% 5:1 Me, H, Me 
26 InOTf3 (20 mol%) 5 h  reflux DCM 77% 5:1 H,Me, Et 
27 AlCl3 (20 mol%) 24 h  reflux DCM 45%c 4:1 H,Me, Et 
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28 TfOH (20 mol%) 18 h  reflux DCM 61%c 1.7:1 H,Me, Et 
29 FeCl3·Al2O3 (20 mol%) 30 h  reflux DCM 89%c 3:1 H,Me, Et 
30 FeCl3·Al2O3 (20 mol%) 1 h reflux DCE >95%e - H,Me, Et 
31 FeCl3·Al2O3 (20 mol%)h 2.5 h rt DCM 86%c 3:1 H,Me, Et 
32 FeCl3·Al2O3 (100 mol%) 2.5 h rt DCM >95%c 1.2:1 H,Me, Et 
33 FeCl3·Al2O3 (100 mol%) 18 h -30 °C DCM <5%d - H,Me, Et 
34 FeCl3·Al2O3 (100 mol%) 20 h -20°C DCM >95% 4:1 H,Me, Et 
35 FeCl3·Al2O3 (100 mol%) 2 h 0 °C DCM >95% 4:1 H,Me, Et 
36 FeCl3·Al2O3 (50 mol%) 5.5 h 0 °C DCM 90% 4:1 H,Me, Et 
37 FeCl3·Al2O3 (100 mol%) 18 h rt DCM >95% 5:1 Ph, H, Me 
38 ScOTf3 (20 mol%) 4 h  rt DCM <5%d - Ph, H, Me 
39 YbOTf3 (20 mol%) 4 h  rt DCM <5%d - Ph, H, Me 
40 SnCl4 (100 mol%) 4 h rt DCM <5%d - Ph, H, Me 
41 FeCl3 (100 mol%) 18 h rt DCM >95%c - Ph, H, Me 
42 FeBr3 (100 mol%) 18 h rt DCM >95%c - Ph, H, Me 
aEstimated by 1H NMR of the crude mixture based on the ratio of product to starting material; 
bDetermined by 1H NMR of the crude; cComplex mixture of products was observed in the 1H NMR of the 
crude; dNo product detected; eDegradation; fNot reproducible; gOpen flask; h3 equivalents of aldehyde. 
 
Optimization procedure for cyclobutane 4e and 4f 
The Lewis acid was added in a flame dried microwave vial and under nitrogen atmosphere. Then, dry 
dichloromethane and benzaldehyde (5a) (7.7 µL, 0.076 mmol, 1.5 eq) were added into the flask. A 
solution of cyclobutane 4 (20 mg, 0.050 mmol, 1.0 eq) in dry dichloromethane was added dropwise to the 
reaction mixture. The reaction mixture was filtrated on a pad of silica eluting with ethyl acetate (10 mL) 
and concentrated under reduce pressure. The crude product was dissolved in ethanol (1.8 mL) and 
ammonium hydroxide solution (0.6 mL, 60 eq, 25 %) was added. The resulting solution was stirred for 16 
hours and the solvent was removed under reduced pressure. The crude mixture was purified by column 
chromatography eluting with a mixture of ethyl acetate/ pentane (5:5 to 9:1).  
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aEstimated by 1H NMR of the crude mixture based on the ratio of product to starting material, b 1H NMR 
yield (traces of benzamide originated from the protecting group) 
  
Entry Catalyst (mol%) Time Conversiona Yieldb 
1 Hf(OTf)4 (20 mol%) 14 h > 95 % 51% 
2 FeCl3·Al2O3 (20 mol%) 14 h > 95 % 59% 
3 Hf(OTf)4 (20 mol%) 30 min > 95 % 76% 
4 FeCl3·Al2O3 (100 mol%) 30 min > 95 % 62% 
5 Hf(OTf)4 (20 mol%) 15 min > 95 % 84% 
6 FeCl3·Al2O3 (100 mol%) 15 min > 95 % 70% 
7 Hf(OTf)4 (10 mol%) 15 min > 95 % 87% 
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4. Scope of the [4+2] Annulation 
 
4.1 General Procedures 
 
General Procedure for the [4+2] annulation reaction of dimethyl 2-(1,3-dioxoisoindolin-2-
yl)cyclobutane-1,1-dicarboxylate (4a). (GP2) 
 
In a glovebox, scandium triflate (19.7 mg, 0.0400 mmol, 0.2 eq) was added to a microwave vial. The vial 
was sealed with a Teflon septum and taken out of the glovebox. Dry dichloromethane (2 mL) was added. 
The cyclobutane 4a (0.200 mmol, 1 eq) was dissolved in dry dichloromethane (2 mL) and added. The 
aldehyde 5 (0.300 mmol, 1.5 eq) was then dissolved in dry dichloromethane (2 mL) and added. The 
reaction was stirred at room temperature for 2.5 h, and then filtered over a pad of basic alumina, eluted 
with ethyl acetate and concentrated under vacuum. The crude product was purified by column 
chromatography using the indicated solvents. 
General Procedure for the [4+2] annulation reaction of dimethyl 2-(1,3-dioxoisoindolin-2-yl)-3-
methylcyclobutane-1,1-dicarboxylate (4b). (GP3) 
 
In a glovebox, iron trichloride supported on alumina (1.00 mmol/g, 200 mg, 0.200 mmol, 1 eq) was added 
to a microwave vial. The vial was sealed with a Teflon septum and taken out of the glovebox. Dry 
dichloromethane (2 mL) was added. The cyclobutane 4b (0.200 mmol, 1 eq) was dissolved in dry 
dichloromethane (2 mL) and added. The aldehyde 5 (0.300 mmol, 1.5 eq) was then dissolved in dry 
dichloromethane (2 mL) and added. The reaction was stirred at room temperature for 5 h, and then filtered 
over a pad of basic alumina, eluted with ethyl acetate and concentrated under vacuum. The crude product 
was purified by column chromatography using the indicated solvents. 
General Procedure for the [4+2] annulation reaction of diethyl 2-(1,3-dioxoisoindolin-2-yl)-4-
methylcyclobutane-1,1-dicarboxylate (4d). (GP4) 
 
In a glovebox, iron trichloride supported on alumina (1.00 mmol/g, 200 mg, 0.200 mmol, 1 eq) was added 
to a microwave vial. The vial was sealed with a Teflon septum and taken out of the glovebox. Dry 
dichloromethane (2 mL) was added. The vial was cooled down at 0 °C with an ice/water bath. The 
cyclobutane 4d (0.200 mmol, 1 eq) was dissolved in dry dichloromethane (2 mL) and added dropwise. 
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The aldehyde 5 (0.300 mmol, 1.5 eq) was then dissolved in dry dichloromethane (2 mL) and added 
dropwise. The reaction was stirred at 0 °C for 2 h, and then filtered over a pad of basic alumina, eluted 
with ethyl acetate and concentrated under vacuum. The crude product was purified by column 
chromatography using the indicated solvents. 
General Procedure for the [4+2] annulation for the synthesis of nucleoside analogues (GP5) 
 
Hf(OTf)4 (21 mg, 0.030 mmol, 0.1 eq) was added in a flame dried 25 mL flask and under nitrogen 
atmosphere. Then, dry dichloromethane (4.5 mL) and aldehyde 5 (0.45 mmol, 1.5 eq) were added into the 
flask. A solution of cyclobutane 4 (0.30 mmol, 1.0 eq) in dry dichloromethane (1.5 mL) was added 
dropwise to the reaction mixture and stirred at room temperature for 15 minutes. The reaction mixture was 
filtrated on a pad of silica eluting with a mixture of ethyl acetate/ pentane (8:2) and concentrated under 
reduce pressure. The crude product was dissolved in ethanol (6 mL) and ammonium hydroxide solution 
(1.8 mL, 60 eq, 25 %) was added. The resulting solution was stirred for 16 hours. The solvent was 
removed under reduced pressure and the crude product was dissolved in ethyl acetate (25 mL) and 
extracted with water (3 x 50 mL). The organic layer was dried over magnesium sulfate, filtrated and 
concentrated under reduced pressure. The crude mixture was purified by column chromatography eluting 
with a mixture of ethyl acetate/ pentane (5:5 to 9:1). The product was recrystallized in ethanol (2 mL). 
General Procedure for the [4+2] annulation with enol ethers (GP6) 
 
4Å MS pellets (ca 20 mg) were added in an oven dried 5 mL round bottom flask. The flask was closed 
with a silicon septum and three cycles of vacuum/N2 were performed. Aminocyclobutane 4a (0.200 mmol, 
1 eq) and silyl enol ether 7 (0.300 mmol, 1.5 eq) were dissolved in dichloromethane (2 mL) and added to 
the reaction flask. The solution was cooled to -40 °C using an acetonitrile/N2 bath. A solution of tin 
tetrachloride (0.43 mol/L, 93.0 µL, 0.0400 mmol, 0.2 eq,) was added dropwise and the reaction was stirred 
at -40 °C until full conversion was observed by NMR. The reaction was then quenched by adding 
triethylamine (0.1 mL) and the solvent was removed under reduced pressure. The reaction was purified by 
column chromatography on Biotage (SNAP cartridge KP-SIL 25 g, 95:5 to 4:6 Hexane/Ethyl acetate) 
affording the aminocyclohexanes. 
 
4.2 Scope of the [4+2] annulation 
Dimethyl 6-(1,3-dioxoisoindolin-2-yl)-2-phenyldihydro-2H-pyran-3,3(4H)-dicarboxylate (6aa) 
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Following the general procedure GP2, dimethyl 2-(1,3-dioxoisoindolin-2-yl)cyclobutane-1,1-
dicarboxylate (4a) (63.5 mg, 0.200 mmol, 1 eq) and benzaldehyde (5a) (31.8 mg, 0.300 mmol, 1.5 eq) 
were stirred at room temperature for 2.5 h. The crude oil was purified by column chromatography (SiO2, 
8:2 Pentane/Ethyl Acetate) affording dimethyl 6-(1,3-dioxoisoindolin-2-yl)-2-phenyldihydro-2H-pyran-
3,3(4H)-dicarboxylate (6aa) (78.0 mg, 0.184 mmol, 92% yield) as a white solid. 
dr 16:1, diastereoisomeric ratio was calculated in 1H NMR of the isolated product integrating peaks at 5.82 
and 5.67. 
The major cis diastereoisomer was characterized. A strong correlation between the signals at 5.67 and 
5.21 was observed. In addition, a large coupling constant (J = 11.6 Hz) of the signal at 5.67 suggests that 
this proton is in axial position in anti-periplanar relationship with one proton of the neighboring CH2. 
1 mmol scale reaction :  
In a glovebox, scandium triflate (24.6 mg, 0.0500 mmol, 0.05 eq) was added to a microwave vial. The vial 
was sealed with a Teflon septum and taken out of the glovebox. Dry dichloromethane (4 mL) was added. 
The cyclobutane 4a (317 mg, 1 mmol, 1 eq) was dissolved in dry dichloromethane (3 mL) and added. The 
benzaldehyde (5a) (159 mg, 1.50 mmol, 1.5 eq) was then dissolved in dry dichloromethane (3 mL) and 
added. The reaction was stirred at room temperature for 5 h, and then was filtered over a pad of alumina, 
eluted with ethyl acetate and concentrated under vacuum. The crude product was purified by column 
chromatography (SiO2, 8:2 Pentane/Ethyl Acetate) affording dimethyl 6-(1,3-dioxoisoindolin-2-yl)-2-
phenyldihydro-2H-pyran-3,3(4H)-dicarboxylate (6aa) (342 mg, 0.808 mmol, 81% yield) as a white solid. 
dr 13:1, diastereoisomeric ratio was calculated in 1H NMR of the isolated product integrating peaks at 5.82 
and 5.67. 
Rf 0.25 (7:3 Pentane/Ethyl Acetate). 
Mp 167-170 °C. 
1H NMR (400 MHz, CDCl3)9 δ 7.87 (dd, J = 5.5, 3.1 Hz, 2 H, Phth), 7.73 (dd, J = 5.5, 3.0 Hz, 2 H, Phth), 
7.40 – 7.36 (m, 2 H, Ph), 7.27 – 7.20 (m, 3 H, Ph), 5.67 (dd, J = 11.6, 3.0 Hz, 1 H, N-C(H)-O), 5.21 (s, 1 
H, O-C(H)-Ph), 3.68 (s, 3 H, OCH3), 3.63 (s, 3 H, OCH3), 3.35 – 3.21 (m, 1 H, CH2), 2.79 (ddd, J = 13.7, 
4.4, 3.1 Hz, 1 H, CH2), 2.29 (ddd, J = 13.6, 13.6, 4.3 Hz, 1 H, CH2), 1.78 (dddd, J = 13.5, 4.3, 3.0, 3.0 Hz, 
1 H, CH2).  
13C NMR (101 MHz, CDCl3) δ 170.9, 168.6, 167.0, 138.3, 134.3, 131.8, 127.8, 127.4, 127.3, 123.6, 82.2, 
79.3, 58.1, 52.6, 51.9, 32.3, 23.8.  
IR 2953 (w), 1781 (w), 1722 (s), 1450 (w), 1440 (w), 1375 (m), 1262 (m), 1209 (w), 1082 (m), 1050 (m), 
1012 (w).  
HRMS (ESI) calcd for C23H21NNaO7+ [M+Na]+ 446.1216; found 446.1213. 
                                                          
9 Small amount of other compound (less than 5%) observed by 1H NMR (probably other diastereoisomer). 
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Dimethyl 2-(4-chlorophenyl)-6-(1,3-dioxoisoindolin-2-yl)dihydro-2H-pyran-3,3(4H)-dicarboxylate 
(6ab) 
 
Following the general procedure GP2, dimethyl 2-(1,3-dioxoisoindolin-2-yl)cyclobutane-1,1-
dicarboxylate (4a) (63.5 mg, 0.200 mmol, 1 eq) and 4-chlorobenzaldehyde (5b) (42.2 mg, 0.300 mmol, 
1.5 eq) were stirred at room temperature for 2.5 h. The crude oil was purified by column chromatography 
(SiO2, 8:2 Pentane/Ethyl Acetate) affording dimethyl 2-(4-chlorophenyl)-6-(1,3-dioxoisoindolin-2-
yl)dihydro-2H-pyran-3,3(4H)-dicarboxylate (6ab) (69.0 mg, 0.151 mmol, 75% yield) as a white solid. 
dr 17:1, diastereoisomeric ratio was calculated in 1H NMR of the isolated product integrating peaks at 5.86 
and 5.6. 
The major diastereoisomer is the cis, in analogy with the 1H NMR spectrum of 6aa. 
Rf 0.33 (7:3 Pentane/Ethyl Acetate). 
Mp 169-176 °C. 
1H NMR (400 MHz, CDCl3)9 only maj diastereoisomer characterized δ 7.87 (dd, J = 5.5, 3.0 Hz, 2 H, 
Phth), 7.74 (dd, J = 5.5, 3.0 Hz, 2 H, Phth), 7.34 – 7.28 (m, 2 H, Ph), 7.23 – 7.18 (m, 2 H, Ph), 5.66 (dd, J 
= 11.7, 3.0 Hz, 1 H, N-C(H)-O), 5.16 (s, 1 H, O-C(H)-Ph), 3.68 (s, 3 H, OCH3), 3.65 (s, 3 H, OCH3), 3.27 
(dddd, J = 13.5, 13.5, 11.6, 4.4 Hz, 1H), 2.78 (ddd, J = 13.7, 4.3, 2.9 Hz, 1 H), 2.27 (ddd, J = 13.6, 13.6, 
4.3 Hz, 1 H), 1.78 (dddd, J = 13.5, 4.3, 3.0, 3.0 Hz, 1H).  
13C NMR (101 MHz, CDCl3) only maj diastereoisomer characterized δ 170.8, 168.3, 167.0, 136.8, 134.4, 
133.5, 131.7, 128.9, 127.4, 123.7, 81.6, 79.3, 58.0, 52.7, 52.0, 32.2, 23.7.  
IR 2953 (w), 1782 (w), 1724 (s), 1439 (w), 1375 (s), 1344 (w), 1262 (m), 1210 (m), 1075 (m), 1052 (m), 
1014 (w).  
HRMS (ESI) calcd for C23H20ClNNaO7+ [M+Na]+ 480.0820; found 480.0820. 
Dimethyl 6-(1,3-dioxoisoindolin-2-yl)-2-(4-methoxyphenyl)dihydro-2H-pyran-3,3(4H)-dicarboxylate 
(6ac) 
 
Following the general procedure GP2, dimethyl 2-(1,3-dioxoisoindolin-2-yl)cyclobutane-1,1-
dicarboxylate (4a) (63.5 mg, 0.200 mmol, 1 eq) and 4-methoxybenzaldehyde (5c) (40.8 mg, 0.300 mmol, 
1.5 eq) were stirred at room temperature for 2.5 h. The crude oil was purified by column chromatography 
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(SiO2, 8:2 to 6:4 Pentane/Ethyl Acetate) affording dimethyl 6-(1,3-dioxoisoindolin-2-yl)-2-(4-
methoxyphenyl)dihydro-2H-pyran-3,3(4H)-dicarboxylate (6ac) (74.6 mg, 0.165 mmol, 82% yield) as a 
white solid. 
dr 6:1, diastereoisomeric ratio was calculated in 1H NMR of the isolated product integrating peaks at 5.79 
and 5.65. 
The major diastereoisomer is the cis, in analogy with the 1H NMR spectrum of 6aa. 
Rf 0.22 (7:3 Pentane/Ethyl Acetate). 
Mp 154-161 °C. 
1H NMR (400 MHz, CDCl3)9 on a 6(maj):1(min) mixture δ 7.89 – 7.77 (m, 2.3 H, Phth maj + min), 7.75 – 
7.65 (m, 2.3 H, Phth maj + min), 7.37 – 7.33 (m, 0.3 H, Ph min), 7.33 – 7.27 (m, 2 H, Ph maj), 6.86 – 6.80 
(m, 0.3 H, Ph min), 6.80 – 6.73 (m, 2 H, Ph min), 6.08 (s, 0.15 H, O-C(H)-Ph min), 5.79 (dd, J = 10.4, 5.3 
Hz, 0.15 H, N-C(H)-O min), 5.65 (dd, J = 11.7, 3.0 Hz, 1 H, N-C(H)-O maj), 5.13 (s, 1 H, O-C(H)-Ph 
maj), 3.87 (s, 0.45 H, OCH3 min), 3.76 (s, 0.45 H, OCH3 min), 3.74 (s, 3 H, OCH3 maj), 3.67(s, 3 H, 
OCH3 maj), 3.66 (s, 3 H, OCH3 maj), 3.40 (s, 0.45 H, OCH3 min), 3.28 (m, 1 H, CH2 maj), 2.85 – 2.69 (m, 
1.15 H, CH2 maj + min), 2.69 – 2.58 (m, 0.3 H, CH2 min), 2.26 (ddd, J = 13.6, 13.6, 4.3 Hz, 1 H, CH2 
maj), 1.97 – 1.88 (m, 0.15 H, CH2 min), 1.81 – 1.72 (m, 1 H, CH2 maj).10  
13C NMR (101 MHz, CDCl3) only maj diastereoisomer characterized δ 170.9, 168.6, 167.0, 159.1, 134.3, 
131.8, 130.4, 128.7, 123.6, 112.6, 82.0, 79.3, 58.1, 55.1, 52.6, 52.0, 32.2, 23.8.  
IR 2954 (w), 1782 (w), 1725 (s), 1615 (w), 1515 (w), 1462 (w), 1440 (w), 1376 (m), 1347 (w), 1253 (m), 
1210 (w), 1076 (m), 1045 (m).  
HRMS (ESI) calcd for C24H23NNaO8+ [M+Na]+ 476.1316; found 476.1319. 
Dimethyl 6-(1,3-dioxoisoindolin-2-yl)-2-(2-methoxyphenyl)dihydro-2H-pyran-3,3(4H)-dicarboxylate 
(6ad) 
 
Following the general procedure GP2, dimethyl 2-(1,3-dioxoisoindolin-2-yl)cyclobutane-1,1-
dicarboxylate (4a) (63.5 mg, 0.200 mmol, 1 eq) and 2-methoxybenzaldehyde (5d) (40.8 mg, 0.300 mmol, 
1.5 eq) were stirred at room temperature for 2.5 h. The crude oil was purified by column chromatography 
(SiO2, 65:35 Pentane/Ethyl Acetate) affording dimethyl 6-(1,3-dioxoisoindolin-2-yl)-2-(2-
methoxyphenyl)dihydro-2H-pyran-3,3(4H)-dicarboxylate (6ad) (82.8 mg, 0.183 mmol, 91% yield) as a 
white solid. 
dr 8.5:1, diastereoisomeric ratio was calculated in 1H NMR of the isolated product integrating peaks at 
6.37 and 5.25. 
The major diastereoisomer is the cis, in analogy with the 1H NMR spectrum of 6aa. 
Rf 0.18 (7:3 Pentane/Ethyl Acetate). 
Mp 87-97 °C. 
1H NMR (400 MHz, CDCl3)9 only maj diastereoisomer characterized δ 7.90 – 7.81 (m, 2 H, Phth), 7.81 – 
7.66 (m, 2 H, Phth, 1 H, Ph), 7.24 – 7.16 (m, 1 H, Ph), 6.93 (dd, J = 7.5 Hz, 1 H, Ph), 6.75 (d, J = 8.1 Hz, 
                                                          
10 Over-integrated due to overlap with water in CDCl3. 
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1 H, Ph), 5.64 (dd, J = 11.5, 3.0 Hz, 1 H, N-C(H)-O), 5.25 (s, 1 H, O-C(H)-Ph), 3.76 (s, 3 H, OCH3), 3.75 
(s, 3 H, OCH3), 3.55 (s, 3 H, OCH3), 3.03 – 2.85 (m, 1 H, CH2), 2.72 (ddd, J = 14.1, 3.8, 3.8 Hz, 1 H, 
CH2), 2.61 – 2.50 (m, 1 H, CH2), 1.80 (dddd, J = 13.5, 3.5, 3.5, 3.5 Hz, 1 H, CH2).  
13C NMR (101 MHz, CDCl3) only maj diastereoisomer characterized δ 169.4, 168.9, 167.1, 155.8, 134.3, 
131.8, 130.5, 128.8, 126.3, 123.6, 119.9, 108.8, 79.4, 76.4, 57.6, 55.2, 52.3, 52.1, 32.1, 24.2.  
IR 2954 (w), 1765 (w), 1724 (s), 1600 (w), 1495 (w), 1464 (w), 1439 (w), 1376 (m), 1293 (w), 1256 (m), 
1200 (w), 1111 (w), 1073 (m), 1050 (m).  
HRMS (ESI) calcd for C24H23NNaO8+ [M+Na]+ 476.1316; found 476.1312. 
(E)-Dimethyl 6-(1,3-dioxoisoindolin-2-yl)-2-styryldihydro-2H-pyran-3,3(4H)-dicarboxylate (6ae) 
 
Following the general procedure GP2, dimethyl 2-(1,3-dioxoisoindolin-2-yl)cyclobutane-1,1-
dicarboxylate (4a) (63.5 mg, 0.200 mmol, 1 eq) and cinnamaldehyde (5e) (39.6 mg, 0.300 mmol, 1.5 eq) 
were stirred at room temperature for 2.5 h. The crude oil was purified by column chromatography (SiO2, 
9:1 to 8:2 Pentane/Ethyl Acetate) affording (E)-dimethyl 6-(1,3-dioxoisoindolin-2-yl)-2-styryldihydro-2H-
pyran-3,3(4H)-dicarboxylate (6ae) (85.7 mg, 0.191 mmol, 95% yield) as a white solid. 
dr 2:1, diastereoisomeric ratio was calculated in 1H NMR of the isolated product integrating peaks at 5.84 
and 5.63. 
The major diastereoisomer is the cis, in analogy with the 1H NMR spectrum of 6aa. 
Rf 0.3 (7:3 Pentane/Ethyl Acetate). 
Mp 88-92 °C. 
1H NMR (400 MHz, CDCl3)9 on a 2(maj):1(min) mixture δ 7.90 – 7.81 (m, 3 H, Phth maj + min), 7.79 – 
7-68 (m, 3 H, Phth maj + min), 7.45 – 7.39 (m, 1 H, Ph min), 7.38 – 7.31 (m, 3 H, Ph maj + min), 7.30 – 
7.17 (m, 3.5 H, Ph maj + min),11 6.85 (dd, J = 15.8, 1.5 Hz, 0.5 H, CH vinyl min), 6.67 (dd, J = 16.0, 7.2 
Hz, 1 H, CH vinyl maj), 6.54 (d, J = 16.1 Hz, 1 H, CH vinyl maj), 6.28 (dd, J = 15.8, 6.4 Hz, 0.5 H, CH 
vinyl min), 5.84 (dd, J = 11.2, 3.4 Hz, 0.5 H, N-C(H)-O min), 5.63 (dd, J = 11.8, 3.0 Hz, 1 H, N-C(H)-O 
maj), 5.47 (ddd, J = 6.4, 1.5, 1.5 Hz, 0.5 H, O-C(H)-vinyl min), 4.60 (dd, J = 7.2, 0.9 Hz, 1 H, O-C(H)-
vinyl maj), 3.94 (s, 1.5 H, OCH3 min), 3.90 (s, 3 H, OCH3 maj), 3.70 (s, 1.5 H, OCH3 min), 3.67 (s, 3 H, 
OCH3 maj), 3.08 (dddd, J = 13.7, 13.7, 11.7, 4.4 Hz, 1 H, CH2 maj), 2.88 – 2.78 (m, 0.5 H, CH2 min), 2.75 
(ddd, J = 13.6, 4.4, 2.8 Hz, 1 H, CH2 maj), 2.67 (dddd, J = 14.3, 3.9, 3.9, 1.6 Hz, 0.5 H, CH2 min), 2.37 
(ddd, J = 13.9, 13.9, 4.1 Hz, 0.5 H, CH2 min), 2.23 (ddd, J = 13.7, 13.7, 4.2 Hz, 1 H, CH2 maj), 1.82 
(dddd, J = 13.8, 3.9, 3.9, 3.9 Hz, 0.5 H, CH2 min), 1.75 (dddd, J = 13.6, 13.6, 4.2, 2.8 Hz, 1 H, CH2 maj). 
 13C NMR (101 MHz, CDCl3) δ 170.4, 169.5, 168.9, 168.8, 167.4, 167.1, 136.5, 136.2, 135.9, 134.4, 
134.3, 132.9, 131.8, 131.7, 128.6, 128.4, 128.2, 127.8, 126.8, 126.8, 125.9, 123.6, 123.6, 121.7, 82.8, 79.0, 
77.2, 72.9, 58.1, 57.1, 53.3, 53.0, 52.8, 52.6, 31.6, 25.2, 23.8, 23.7.  
IR 3027 (w), 2953 (w), 1781 (w), 1724 (s), 1452 (w), 1442 (w), 1376 (m), 1269 (w), 1253 (w), 1209 (w), 
1071 (m), 1010 (w).  
HRMS (ESI) calcd for C25H23NNaO7+ [M+Na]+ 472.1367; found 472.1371. 
Dimethyl 6-(1,3-dioxoisoindolin-2-yl)-5-methyl-2-phenyldihydro-2H-pyran-3,3(4H)-dicarboxylate 
(6ba) 
                                                          
11 Over-integrated due to overlap with CHCl3 peak. 
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Following the general procedure GP3, dimethyl 2-(1,3-dioxoisoindolin-2-yl)-3-methylcyclobutane-
1,1-dicarboxylate (4b) (66.3 mg, 0.200 mmol, 1 eq) and benzaldehyde (5a) (31.8 mg, 0.300 mmol, 1.5 eq) 
were stirred at room temperature for 5 h. The crude oil was purified by column chromatography (SiO2, 8:2 
Pentane/Ethyl Acetate) affording dimethyl 6-(1,3-dioxoisoindolin-2-yl)-5-methyl-2-phenyldihydro-2H-
pyran-3,3(4H)-dicarboxylate (6ba) (56.0 mg, 0.128 mmol, 64% yield) as a white solid. 
dr 5:1, diastereoisomeric ratio was calculated in 1H NMR of the isolated product integrating peaks at 2.73 
and 2.56. 
The major diastereoisomer is the cis-trans, in analogy with the 1H NMR spectrum of 6bb. 
Rf 0.36 (7 :3 Pentane/Ethyl Acetate). 
Mp 79-86 °C. 
1H NMR (400 MHz, CDCl3) on a 5(maj):1(min) mixture δ 7.88 (dd, J = 5.4, 3.0 Hz, 2 H, Phth maj), 7.82 
(dd, J = 5.5, 3.1 Hz, 0.4 H, Phth min), 7.74 (dd, J = 5.5, 3.0 Hz, 2 H, Phth maj), 7.71 (dd, J = 5.5, 3.1 Hz, 
0.4 H, Phth min) 7.45 – 7.41 (m, 0.4 H, Ph min), 7.40 – 7.35 (m, 2 H, Ph maj), 7.34 – 7.18 (m, 3.6 H, Ph 
maj + min),11 6.24 (s, 0.2 H, O-C(H)-Ph min), 5.33 (d, J = 10.5 Hz, 0.2 H, N-C(H)-O min), 5.26 (d, J = 
10.6 Hz, 1 H, N-C(H)-O maj), 5.18 (s, 1 H, O-C(H)-Ph maj), 3.89 (s, 0.6 H, OCH3 min), 3.68 (s, 3 H, 
OCH3 maj), 3.62 (s, 3 H, OCH3 maj), 3.47 – 3.34 (m, 1 H, Me-CH maj), 3.33 (s, 0.6 H, OCH3 min), 3.09 – 
2.96 (m, 0.2 H, Me-CH min), 2.72 (dd, J = 13.7, 4.2 Hz, 1 H, CH2 maj), 2.55 (dd, J = 14.2, 3.6 Hz, 0.2 H, 
CH2 min), 2.42 (dd, J = 14.2, 13.1 Hz, 0.2 H, CH2 min), 1.95 (dd, J = 13.7, 12.4 Hz, 1 H, CH2 maj), 0.95 
(d, J = 8.0 Hz, 0.6 H, CH3 min), 0.93 (d, J = 6.8 Hz, 3 H, CH3 maj).  
13C NMR (101 MHz, CDCl3)12 δ 170.7, 169.5, 168.7, 167.9, 167.1, 138.2, 137.5, 134.34, 134.30, 131.7, 
128.1, 128.0, 127.8, 127.6, 127.4, 127.3, 123.6, 123.5, 84.9, 82.2, 81.0, 77.3, 76.2, 59.9, 59.3, 53.2, 52.6, 
52.5, 51.9, 40.5, 34.4, 27.7, 27.0, 16.9, 16.2.  
IR 2956 (w), 1774 (w), 1727 (s), 1461 (w), 1439 (w), 1376 (m), 1261 (m), 1214 (w), 1090 (w), 1026 (w). 
HRMS (ESI) calcd for C24H23NNaO7+ [M+Na]+ 460.1367; found 460.1367. 
Dimethyl 2-(4-chlorophenyl)-6-(1,3-dioxoisoindolin-2-yl)-5-methyldihydro-2H-pyran-3,3(4H)-
dicarboxylate (6bb) 
 
Following the general procedure GP3, dimethyl 2-(1,3-dioxoisoindolin-2-yl)-3-methylcyclobutane-
1,1-dicarboxylate (4b) (66.3 mg, 0.200 mmol, 1 eq) and 4-chlorobenzaldehyde (5b) (42.2 mg, 0.300 
mmol, 1.5 eq) were stirred at room temperature for 5 h. The crude oil was purified by column 
chromatography (SiO2, 8:2 Pentane/Ethyl Acetate) affording dimethyl 2-(4-chlorophenyl)-6-(1,3-
dioxoisoindolin-2-yl)-5-methyldihydro-2H-pyran-3,3(4H)-dicarboxylate (6bb) (58.0 mg, 0.123 mmol, 
62% yield) as a white solid. 
dr 5:1, diastereoisomeric ratio was calculated in 1H NMR of the isolated product integrating peaks at 5.35 
and 5.25. 
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The major cis-trans diastereoisomer was characterized. Strong correlations between the signals at 5.25 and 
5.14, and between 5.25 and 0.92 were observed. In addition, a large coupling constant (J = 10.6 Hz) of the 
signal at 5.25 suggests that this proton is in axial position in anti-periplanar relationship with the proton of 
the neighboring CH. 
Rf 0.38 (7:3 Pentane/Ethyl Acetate). 
Mp 81-90 °C. 
1H NMR (400 MHz, CDCl3)9 on a 5(maj):1(min) mixture δ 7.87 (dd, J = 5.6, 3.2 Hz, 2 H, Phth maj), 7.83 
(dd, J = 5.5, 3.1 Hz, 0.4 H, Phth min), 7.75 (dd, J = 5.5, 3.1 Hz, 2 H, Phth maj), 7.71 (dd, J = 5.6, 2.8 Hz, 
0.4 H, Phth min), 7.41 – 7.35 (m, 0.4 H, Ph min), 7.34 – 7.24 (m, 2.4 H, Ph maj + min), 7.23 – 7.16 (m, 2 
H, Ph maj), 6.22 (s, 0.2 H, O-C(H)-Ph min), 5.35 (d, J = 10.4 Hz, 0.2 H, N-C(H)-O min), 5.25 (d, J = 10.6 
Hz, 1 H, N-C(H)-O maj), 5.14 (s, 1 H, O-C(H)-Ph maj), 3.87 (s, 0.6 H, OCH3 min), 3.68 (s, 3 H, OCH3 
maj), 3.64 (s, 3 H, OCH3 maj), 3.44 – 3.35 (m, 1 H, Me-CH maj), 3.34 (s, 0.6 H, OCH3 min), 3.05 – 2.94 
(m, 0.2 H, Me-CH min), 2.71 (dd, J = 13.7, 4.2 Hz, 1 H, CH2 maj), 2.50 (dd, J = 14.2, 3.5 Hz, 0.2 H, CH2 
min), 2.40 (dd, J = 14.3, 13.1 Hz, 0.2 H, CH2 min), 1.93 (dd, J = 13.7, 12.4 Hz, 1 H, CH2 min), 0.95 (d, J = 
6.6 Hz, 0.6H, CH3 min), 0.92 (d, J = 6.6 Hz, 3 H, CH3 maj).  
13C NMR (101 MHz, CDCl3)12 δ  170.7, 170.5, 169.4, 168.4, 167.9, 167.1, 136.7, 136.2, 134.4, 133.8, 
133.5, 131.7, 129.0, 128.9, 128.2, 127.4, 123.7, 123.6, 84.8, 81.5, 81.3, 75.4, 60.2, 59.2, 53.2, 52.7, 52.5, 
52.0, 40.4, 34.5, 27.6, 26.7, 17.0, 16.2.  
IR 2975 (w), 2882, (w), 1780 (w), 1726 (s), 1377 (m), 1263 (m), 1215 (w), 1084 (m), 1021 (w).  
HRMS (ESI) calcd for C24H22ClKNO7+ [M+K]+ 510.0716; found 510.0715.  
 
Dimethyl 6-(1,3-dioxoisoindolin-2-yl)-2,5-diphenyldihydro-2H-pyran-3,3(4H)-dicarboxylate 
(6ca) 
 
In a glovebox, iron trichloride supported on alumina (1.00 mmol/g, 200 mg, 0.200 mmol, 1 eq) was added 
to a microwave vial. The vial was sealed with a Teflon septum and taken out of the glovebox. Dry 
dichloromethane (2 mL) was added. Dimethyl 2-(1,3-dioxoisoindolin-2-yl)-3-phenylcyclobutane-1,1-
dicarboxylate (4c) (79.0 mg, 0.200 mmol, 1 eq) was dissolved in dry dichloromethane (2 mL) and added. 
Benzaldehyde (5a) (31.8 mg, 0.300 mmol, 1.5 eq) was then dissolved in dry dichloromethane (2 mL) and 
added. The mixture was stirred at room temperature for 16 h and then filtered over a pad of basic alumina, 
eluted with ethyl acetate and concentrated under vacuum. The crude oil was purified by column 
chromatography (SiO2, 8:2 Pentane/Ethyl Acetate) affording dimethyl 6-(1,3-dioxoisoindolin-2-yl)-2,5-
                                                          
12 Some peaks are not resolved in the aromatic region. 
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diphenyldihydro-2H-pyran-3,3(4H)-dicarboxylate (6ca) (53.0 mg, 0.106 mmol, 53% yield) as a white 
solid. 
dr 6:1, diastereoisomeric ratio was calculated in 1H NMR of the isolated product integrating peaks at 4.70 
and 4.25. 
Rf 0.16 (8 :2 Pentane/Ethyl Acetate). 
Mp 222-228 °C. 
1H NMR (400 MHz, CDCl3) on a 5(maj):1(min) mixture δ 7.94 – 7.57 (m, 4.8 H, Phth maj + min),13 7.54 
– 7.10 (m, 12 H, 2 x Ph maj + min),13 6.34 (s, 0.2 H, O-C(H)-Ph min), 5.83 (d, J = 10.8 Hz, 1 H, N-C(H)-
O maj), 5.81 (d, J = 10.4 Hz, 0.2 H, N-C(H)-O min) 5.42 (s, 1 H, O-C(H)-Ph maj),13 4.70 (ddd, J = 12.8, 
10.9, 4.1 Hz, 1 H, Ph-C(H)-CH2 maj), 4.25 (ddd, J = 13.9, 10.8, 3.3 Hz, 0.2 H, Ph-C(H)-CH2 min), 3.92 (s, 
0.6 H, OCH3 min),13 3.68 (s, 3 H, OCH3 maj),13 3.66 (s, 3 H, OCH3 maj),13 3.34 (s, 0.6 H, OCH3 min),13 
2.89 (dd, J = 13.7, 4.2 Hz, 1 H, CH2 maj), 2.75 (dd, J = 14.2, 3.4 Hz, 0.2 H, CH2 min), 2.42 (dd, J = 13.2, 
13.2 Hz, 1 H, CH2 maj),13 2.01 – 1.91 (m, 0.6 H, CH2 min). 
13C NMR (101 MHz, CDCl3) only maj diastereoisomer characterized δ 170.5, 168.6, 166.9, 139.0, 138.1, 
134.2, 128.9, 127.9, 127.7, 127.6, 127.5, 127.4, 127.3, 123.5, 83.0, 82.3, 59.1, 52.7, 52.0, 40.7, 39.1.  
IR 3064 (w), 3034 (w), 2953 (w), 1723 (s), 1438 (w), 1374 (m), 1254 (m), 1216 (m), 1065 (m).  
HRMS (ESI) calcd for C29H25KNO7+ [M+K]+ 538.1268; found 538.1277. 
Diethyl 6-(1,3-dioxoisoindolin-2-yl)-4-methyl-2-phenyldihydro-2H-pyran-3,3(4H)-dicarboxylate 
(6da) 
 
Following the general procedure GP4, diethyl 2-(1,3-dioxoisoindolin-2-yl)-4-methylcyclobutane-1,1-
dicarboxylate (4d) (71.9 mg, 0.200 mmol, 1 eq) and benzaldehyde (5a) (31.8 mg, 0.300 mmol, 1.5 eq) 
were stirred at 0 °C for 2 h. The crude oil was purified by column chromatography (SiO2, 8:2 
Pentane/Ethyl Acetate) affording diethyl 6-(1,3-dioxoisoindolin-2-yl)-4-methyl-2-phenyldihydro-2H-
pyran-3,3(4H)-dicarboxylate (6da) (58.8 mg, 0.126 mmol, 63% yield, 95% pure) as a white solid. 
dr 3:1, diastereoisomeric ratio was calculated in 1H NMR of the isolated product integrating peaks at 5.82 
and 5.71. 
The major diastereoisomer is the cis-trans, in analogy with the 1H NMR spectrum of (6db) 
Rf 0.41 (7:3 Pentane/Ethyl Acetate). 
Mp 133-139 °C. 
1H NMR (400 MHz, CDCl3)14 on a 3(maj):1(min) mixture δ 7.85 (ddd, J = 8.4, 5.4, 3.1 Hz, 2.6 H, Phth 
maj + min), 7.71 (ddd, J = 8.5, 5.5, 3.1 Hz, 2.6 H, Phth maj + min), 7.53 – 7.43 (m, 2 H, Ph maj), 7.33 (m, 
0.6 H, Ph min), 7.25 – 7.13 (m, 3.9 H, Ph maj + min), 5.82 (dd, J = 11.8, 3.0 Hz, 1 H, N-C(H)-O maj), 
5.71 (dd, J = 11.8, 2.9 Hz, 0.3 H, N-C(H)-O min), 5.48 (s, 1 H, O-C(H)-Ph maj), 5.17 (s, 0.3 H, O-C(H)-
Ph min), 4.26 – 3.90 (m, 5.2 H, 2 x OCH2 maj + min), 3.69 (dddd, J = 10.7, 7.0, 7.0, 7.0 Hz, 1 H, CH2 
maj), 3.40 (m, 0.3, CH2 min),17 3.06 – 2.94 (m, 1 H, Me-CH maj),17 2.60 – 2.48 (m, 0.3 H, Me-CH min),17 
                                                          
13 Overlapping with signals of impurities (probably other diastereoisomers present in less than 10% each). 
14 95% pure (other diastereoisomer not characterized and 5% impurity). 
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1.75 – 1.63 (m, 0.3 H, CH2 min),10,17 1.56 (ddd, J = 13.4, 3.1, 3.1 Hz, 1 H, CH2 maj),17 1.26 (d, J = 7.2 Hz, 
3 H, CH3 maj), 1.25 (d, J = 6.8 Hz, 0.9 H, CH3 min), 1.20 (m, 3.9 H, OCH2CH3 maj + min), 1.09 (t, J = 
7.1 Hz, 0.9 H, OCH2CH3 min), 0.88 (t, J = 7.2 Hz, 3 H, OCH2CH3 maj).  
13C NMR (101 MHz, CDCl3)12 δ 170.2, 169.5, 168.6, 167.1, 167.0, 166.7, 138.8, 138.5, 134.2, 131.8, 
128.2, 127.6, 127.3, 127.2, 127.1, 123.5, 123.5, 83.2, 79.3, 77.2, 76.7, 75.3, 62.9, 61.4, 60.9, 60.7, 60.5, 
60.3, 39.2, 32.8, 31.2, 30.5, 17.5, 16.4, 14.0, 13.7, 13.3.  
IR 2982 (w), 2983 (w), 2904 (w), 1780 (w), 1723 (s), 1464 (w), 1373 (s), 1287 (w), 1258 (m), 1230 (m), 
1201 (m), 1090 (m), 1048 (m), 1033 (m).  
HRMS (ESI) calcd for C26H28NO7+ [M+H]+ 466.1860; found 466.1852. 
Diethyl 2-(4-chlorophenyl)-6-(1,3-dioxoisoindolin-2-yl)-4-methyldihydro-2H-pyran-3,3(4H)-
dicarboxylate (6db) 
 
Following the general procedure GP4, diethyl 2-(1,3-dioxoisoindolin-2-yl)-4-methylcyclobutane-1,1-
dicarboxylate (4d) (71.9 mg, 0.200 mmol, 1 eq) and 4-chlorobenzaldehyde (5b) (42.2 mg, 0.300 mmol, 
1.5 eq) were stirred at 0 °C for 2 h. The crude oil was purified by column chromatography (SiO2, 8:2 
Pentane/Ethyl Acetate) affording dimethyl 2-(4-chlorophenyl)-6-(1,3-dioxoisoindolin-2-yl)-5-
methyldihydro-2H-pyran-3,3(4H)-dicarboxylate (6db) (81 mg, 0.162 mmol, 81% yield, 90% pure) as a 
colorless oil. 
dr 3:1, diastereoisomeric ratio was calculated in 1H NMR of the isolated product integrating peaks at 5.80 
and 5.69. 
The major cis-trans diastereoisomer was characterized. Strong correlations between the signals at 5.80 and 
5.44, 5.80 and 1.27-1.17, and 5.44 and 1.27-1.17 were observed. This suggests an axial orientation for the 
three substituents. In addition, a large coupling constant (J = 12 Hz) of the signal at 5.80 suggests that this 
proton is in axial position in anti-periplanar relationship with a proton of the neighboring CH2. 
Rf 0.43 (7:3 Pentane/Ethyl Acetate). 
1H NMR (400 MHz, CDCl3)15 on a 3(maj):1(min) mixture δ 7.92 – 7.77 (m, 2.6 H, Phth maj + min),16 
7.77 – 7.65 (m, 2.6 H, Phth maj + min), 7.48 – 7.38 (m, 2 H, Ph maj), 7.31 – 7.23 (m, 0.6 H, Ph min),11 
7.23 – 7.13 (m, 2.6 H, Ph maj + min),16 5.80 (dd, J = 12.0, 2.8 Hz, 1 H, N-C(H)-O maj), 5.69 (dd, J = 11.8, 
2.9 Hz, 0.3 H, N-C(H)-O min), 5.44 (s, 1 H, O-C(H)-Ph maj), 5.13 (s, 0.3 H, O-C(H)-Ph min), 4.28 – 3.89 
(m, 5.2 H, 2 x OCH2 maj + min), 3.82 – 3.67 (m, 1 H, CH2 maj),16,17 3.43 – 3.30 (m, 0.3 H, CH2 min),17 
3.04 – 2.91 (m, 1 H, Me-CH maj),17 2.57 – 2.45 (m, 0.3 H, Me-CH min),17 1.68 (ddd, J = 13.5, 3.6, 3.6 Hz, 
0.3 H, CH2 min),17 1.55 (ddd, J = 13.4, 2.8, 2.8 Hz, 1 H, CH2 maj),17 1.27 – 1.17 (m, 7.8 H, 2 x CH3 maj + 
min, 2 x OCH2CH3 maj  + min),16 1.12 (t, J = 7.1 Hz, 0.6 H, OCH2CH3 min),16 0.94 (t, J = 7.2 Hz, 3 H, 
OCH2CH3 maj).  
                                                          
15 90 % pure. 
16 Overlapping with signals of another diastereoisomer present in less than 10% and impurity. 
17 Attributed by HSQC. 
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13C NMR (101 MHz, CDCl3)18 δ 170.2, 169.4, 168.3, 167.1, 167.0, 166.6, 137.4, 137.1, 134.3, 134.3, 
133.4, 131.7, 129.7, 128.8, 128.3, 127.8, 127.4, 127.2, 123.6, 82.6, 79.3, 76.5, 75.4, 62.8, 61.5, 61.1, 60.9, 
60.7, 60.2, 39.3, 32.8, 31.1, 30.4, 17.6, 16.3, 14.04, 13.98, 13.8, 13.5.  
IR 2982 (w), 2983 (w), 2904 (w), 1780 (w), 1723 (s), 1464 (w), 1374 (s), 1287 (w), 1258 (m), 1230 (m), 
1201 (m), 1090 (m), 1043 (m), 1033 (m).  
HRMS (ESI) calcd for C26H26NO7ClNa+ [M+Na]+ 522.1290; found 522.1277. 
 
Diastereoisomeric resolution of diethyl 2-(1,3-dioxoisoindolin-2-yl)-4-methylcyclobutane-
1,1-dicarboxylate (86) 
 
In a glovebox, indium triflate (22.5 mg, 0.0400 mmol, 0.2 eq) was added to a microwave vial. The vial 
was sealed with a Teflon septum and taken out of the glovebox. Dry dichloromethane (2 mL) was added. 
Diethyl 2-(1,3-dioxoisoindolin-2-yl)-4-methylcyclobutane-1,1-dicarboxylate (4d) (71.9 mg, 0.200 mmol, 
dr 1.1:1, 1 eq) was dissolved in dry dichloromethane (2 mL) and added. 2-Methoxybenzaldehyde (5d) 
(22.5 mg, 0.300 mmol, 1.5 eq) was then dissolved in dry dichloromethane (2 mL) and added. The reaction 
was stirred at room temperature for 2 h, and then was filtered over a pad of alumina, eluted with ethyl 
acetate and concentrated under vacuum. The crude product was purified by column chromatography 
(SiO2, 85:15 Pentane/Ethyl Acetate) affording diethyl 2-(1,3-dioxoisoindolin-2-yl)-4-methylcyclobutane-
1,1-dicarboxylate  (4d) (42.4 mg, 0.117 mmol, quantitative yield for the major diastereoisomer) as a pale 
yellow oil. 
dr 14:1, diastereoisomeric ratio was calculated in 1H NMR of the isolated product integrating peaks at 5.58 
and 4.91. 
The major trans diastereoisomer was characterized. Strong correlations between the signals at 5.58 and 
1.98, 5.58 and 1.14, and 1.98 and 1.14 were observed. 
Rf 0.44 (6:4 Pentane/Ethyl Acetate). 
1H NMR (400 MHz, CDCl3) only maj diastereoisomer characterized δ 7.82 (dd, J = 5.4, 3.0 Hz, 2 H, 
Phth), 7.70 (dd, J = 5.5, 3.0 Hz, 2 H, Phth), 5.58 (ddd, J = 9.9, 8.3, 1.2 Hz, 1 H, N-CH), 4.21 (q, J = 7.1 
Hz, 2 H, OCH2),19 3.97 (m, 2 H, OCH2),19 3.65 – 3.54 (m, 1 H, CH3-CH), 3.20 (ddd, J = 11.7, 10.0, 8.3 
Hz, 1 H, CH2), 1.98 (ddd, J = 11.7, 10.0, 5.4 Hz, 1 H, CH2), 1.23 (t, J = 7.1 Hz, 3 H, OCH2CH3), 1.14 (d, J 
= 7.3 Hz, 3 H, CH3), 0.90 (t, J = 7.1 Hz, 3 H, OCH2CH3).  
                                                          
18 One aromatic carbon not resolved. 
19 Overlapping with signals of the minor diastereoisomer. 
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13C NMR (101 MHz, CDCl3) only maj diastereoisomer characterized δ 168.5, 168.4, 168.1, 134.1, 131.8, 
123.3, 62.0, 61.7, 61.6, 45.1, 31.1, 28.7, 16.2, 14.2, 13.6.  
IR 2980 (w), 2943 (w), 2911 (w), 2876 (w), 1779 (w), 1719 (s), 1465 (w), 1376 (s), 1335 (w), 1256 (s), 
1216 (m), 1153 (w), 1116 (w), 1091 (w), 1041 (m).  
HRMS (ESI) calcd for C19H21NNaO6+ [M+Na]+ 382.1261; found 382.1265. 
 
Dimethyl (5-methyl-2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl)-2-phenyldihydro-2H-pyran-3,3(4H)-
dicarboxylate (6ea) 
 
Following the general procedure GP5, using benzaldehyde (5a) (46 µL, 0.45 mmol, 1.5 eq) cyclobutane 
4e (120 mg, 0.300 mmol, 1.0 eq), a mixture of diastereoisomers (20:1 by integration of methyl esters at 
3.52 ppm and 3.49 ppm) 6ea (102 mg, 0.255 mmol, 85% NMR yield)20 was obtained after column 
chromatography as a colorless foam. After recrystallization in ethanol, the pure product 6ea (94 mg, 0.23 
mmol, 78% isolated yield) was obtained as a colorless foam and as a mixture of diastereoisomers (> 20:1 
by integration of methyl esters at 3.52 ppm and 3.49 ppm). 
Rf  0.27 (3:7 Pentane/Ethyl acetate). 
Mp 226.2- 227.9 °C. 
1H NMR (400 MHz, Chloroform-d, major diastereoisomer) δ 8.38 (s, 1 H, NH), 7.40 - 7.35 (m, 2 H, Ar-
H), 7.34 – 7.27 (m, 4 H, Ar-H and thymine C=C-H), 5.96 (dd, J = 11.1, 2.9 Hz, 1 H, tetrahydropyran-
NCH), 5.23 (s, 1 H, tetrahydropyran-CH), 3.68 (s, 3 H, ester CH3), 3.52 (s, 3 H, ester CH3), 2.74 – 2.64 
(m, 1 H, tetrahydropyran-CH2), 2.38 (tdd, J = 12.6, 11.0, 4.1 Hz, 1 H, tetrahydropyran-CH2), 2.25 (td, J = 
13.4, 4.1 Hz, 1 H, tetrahydropyran-CH2), 1.99 (d, J = 1.2 Hz, 3 H, thymine-CH3), 1.97 – 1.90 (m, 1 H, 
tetrahydropyran-CH2).  
13C NMR (101 MHz, Chloroform-d, major diastereoisomer) δ 170.3, 169.2, 163.4, 149.9, 137.5, 135.4, 
128.5, 127.7, 127.5, 111.6, 82.3, 82.1, 57.1, 52.8, 52.0, 31.6, 26.6, 12.8.  
IR 3191 (w), 3041 (w), 2954 (w), 2361 (w), 1725 (s), 1693 (s), 1461 (w), 1271 (s), 1096 (w), 1043 (w), 
915 (w), 735 (m).  
HRMS (ESI) calcd for C20H22N2NaO7+ [M+Na]+ 425.1319, found 425.1324. 
 
Dimethyl 2-(4-fluorophenyl)-6-(5-methyl-2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl)dihydro-2H-
pyran-3,3(4H)-dicarboxylate (6ef). 
                                                          
20 Benzamide as impurity which is not possible to separate by column chromatography. 
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Following the general procedure GP5, using 4-fluorobenzaldehyde (5f) (48 µL, 0.45 mmol, 1.5 eq) 
cyclobutane 4e (120 mg, 0.300 mmol, 1.0 eq), a mixture of diastereoisomers (12:1 by integration of 
methyl esters at 3.54 ppm and 3.49 ppm) 6ef (99 mg, 0.24 mmol, 79% NMR yield)20 was obtained after 
column chromatography as a colorless foam. After recrystallization in ethanol, the pure product 6ef (88 
mg, 0.21 mmol, 70% isolated yield) was obtained as a colorless foam and as a mixture of diastereoisomers 
(12:1 by integration of methyl esters at 3.54 ppm and 3.49 ppm). 
Rf  0.30 (3:7 Pentane/Ethyl acetate). 
Mp 94.8- 96.9°C. 
1H NMR (400 MHz, Chloroform-d, major diastereoisomer) δ 8.06 (s, 1 H, NH), 7.40 – 7.33 (m, 2 H, Ar-
H), 7.29 (d, J = 1.3 Hz, 1 H, thymine C=C-H), 7.03 – 6.95 (m, 2 H, Ar-H), 5.95 (dd, J = 11.3, 2.9 Hz, 1 H, 
tetrahydropyran-NCH), 5.21 (s, 1 H, tetrahydropyran-CH), 3.69 (s, 3 H, ester CH3), 3.54 (s, 3 H, ester 
CH3), 2.74 – 2.63 (m, 1 H, tetrahydropyran-CH2), 2.48 – 2.32 (m, 1 H, tetrahydropyran-CH2), 2.32 – 2.20 
(m, 1 H, tetrahydropyran-CH2), 1.99 (d, J = 1.2 Hz, 3 H, thymine-CH3), 1.93 (dq, J = 9.3, 3.3 Hz, 1 H, 
tetrahydropyran-CH2).  
13C NMR (101 MHz, Chloroform-d, major diastereoisomer) δ 170.3, 169.1, 163.6, 162.5 (d, J = 225.5 
Hz), 150.2, 135.2, 133.4 (d, J = 3.3 Hz), 129.3 (d, J = 8.1 Hz), 114.6 (d, J = 21.4 Hz), 111.8, 82.0, 81.6, 
57.0, 52.8, 52.1, 31.4, 26.5, 12.8.  
IR 3203 (w), 3055 (w), 2961 (w), 2361 (w), 2255 (w), 1724 (s), 1691 (s), 1515 (w), 1464 (w), 1267 (s), 
1229 (m), 1100 (m), 1050 (m), 913 (m), 735 (m).  
HRMS (ESI) calcd for C20H21FN2NaO7+ [M+Na]+ 443.1225; found 443.1224. 
 
Dimethyl 2-(4-methoxyphenyl)-6-(5-methyl-2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl)dihydro-2H-
pyran-3,3(4H)-dicarboxylate (6ec). 
 
Following the general procedure GP5,  using p-anisaldehyde (5c) (55 µL, 0.45 mmol, 1.5 eq) cyclobutane 
4e (120 mg, 0.300 mmol, 1.0 eq), a mixture of diastereoisomers (5:1 by integration of methyl esters at 
3.55 ppm and 3.49 ppm) 6ec (115 mg, 0.264 mmol, 88% NMR yield)20 was obtained after column 
chromatography as a slightly yellow foam. After recrystallization in ethanol, the pure product 6ec (99 mg, 
0.22 mmol, 76% isolated yield) was obtained as a slightly yellow foam and as a mixture of 
diastereoisomers (7:1 by integration of methyl esters at 3.55 ppm and 3.49 ppm). 
Rf  0.26 (3:7 Pentane/Ethyl acetate). 
Mp 97.4- 99.5 °C.  
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1H NMR (400 MHz, Chloroform-d, major diastereoisomer) 9.03 (s, 1 H, NH), 7.31 (d, J = 1.3 Hz, 1 H, 
thymine C=C-H), 7.30 – 7.27 (m, 2 H, Ar-H), 6.86 – 6.78 (m, 2 H, Ar-H), 5.95 (dd, J = 11.1, 2.9 Hz, 1H, 
tetrahydropyran-NCH), 5.16 (s, 1 H, tetrahydropyran-CH), 3.78 (s, 3 H, O-Me CH3), 3.67 (s, 3 H, ester 
CH3), 3.55 (s, 3 H, ester CH3), 2.74 – 2.61 (m, 1 H, tetrahydropyran-CH2), 2.35 (tdd, J = 12.6, 11.0, 4.1 
Hz, 1 H, tetrahydropyran-CH2), 2.22 (td, J = 13.4, 4.1 Hz, 1 H, tetrahydropyran-CH2), 1.97 (d, J = 1.3 Hz, 
3 H, thymine-CH3), 1.95 – 1.88 (m, 1 H, tetrahydropyran-CH2).  
13C NMR (101 MHz, Chloroform-d, major diastereoisomer) δ 170.3, 169.3, 163.7, 159.5, 150.2, 135.4, 
129.6, 128.8, 113.0, 111.6, 82.0, 82.0, 57.0, 55.3, 52.7, 52.1, 31.4, 26.6, 12.8.  
IR 3191 (w), 3049 (w), 2954 (w), 2839 (w), 2360 (w), 2257 (w), 1687 (s), 1517 (w), 1461 (m), 1255 (s), 
1109 (m), 1044 (m), 910 (m), 817 (w), 730 (s).  
HRMS (ESI) calcd for for C21H24N2NaO8
+ [M+Na]+ 455.1425; found 455.1428. 
 
Dimethyl 2-(2-methoxyphenyl)-6-(5-methyl-2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl)dihydro-2H-
pyran-3,3(4H)-dicarboxylate (6ed): 
 
Following the general procedure GP5, using o-anisaldehyde (5d) (61 mg, 0.45 mmol, 1.5 eq) cyclobutane 
4e (120 mg, 0.300 mmol, 1.0 eq), a mixture of diastereoisomers (10:1 by integration of methyl esters at 
3.54 ppm and 3.40 ppm) 6ed (108 mg, 0.252 mmol, 84% NMR yield)20 was obtained after column 
chromatography as a white solid. After recrystallization in ethanol, the pure product 6ed (98 mg, 0.23 
mmol, 76% isolated yield) was obtained as white solid and as a mixture of diastereoisomers (10:1 by 
integration of methyl esters at 3.54 ppm and 3.40 ppm). 
Rf  0.29 (3:7 Pentane/Ethyl acetate). 
Mp 193.9- 196.2 °C. 
1H NMR (400 MHz, Chloroform-d, major diastereoisomer) δ 8.05 (s, 1 H, NH), 7.77 (dd, J = 7.8, 1.7 Hz, 
1 H, Ar-H), 7.39 (d, J = 1.4 Hz, 1 H, thymine C=C-H), 7.31 – 7.27 (m, 1 H, Ar-H), 7.01 (td, J = 7.6, 1.1 
Hz, 1 H, Ar-H), 6.80 (dd, J = 8.3, 1.1 Hz, 1 H, Ar-H), 5.92 (dd, J = 11.0, 3.0 Hz, 1 H, tetrahydropyran-
NCH), 5.29 (s, 1 H, tetrahydropyran-CH), 3.77 (s, 3 H, O-Me CH3), 3.69 (s, 3 H, ester CH3), 3.54 (s, 3 H, 
ester CH3), 2.63 – 2.55 (m, 2 H, tetrahydropyran-CH2), 2.05 – 2.01 (m, 1 H, tetrahydropyran-CH2), 1.99 
(d, J = 1.3 Hz, 3 H, thymine-CH3), 1.85 – 1.74 (m, 1 H, tetrahydropyran-CH2).  
13C NMR (101 MHz, Chloroform-d, major diastereoisomer) δ 169.0, 168.9, 163.8, 156.2, 150.0, 135.7, 
129.9, 129.4, 125.6, 120.3, 111.5, 109.4, 82.2, 76.4, 56.9, 55.5, 52.5, 52.3, 31.1, 27.3, 12.9.  
IR 3191 (w), 3045 (w), 2955 (w), 2841 (w), 2361 (w), 2338 (w), 2253 (w), 1731 (s), 1690 (s), 1464 (m), 
1377 (w), 1259 (s), 1104 (m), 1047 (m), 914 (m), 733 (s).  
HRMS (ESI) calcd for C21H24N2NaO8+ [M+Na]+ 455.1425; found 455.1429. 
 
Dimethyl 6-(5-methyl-2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl)-2-(thiophen-2-yl)dihydro-2H-
pyran-3,3(4H)-dicarboxylate (6eg). 
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Following the general procedure GP5,  using thiophene-2-carbaldehyde (5g) (42 µL, .45 mmol, 1.5 eq) 
cyclobutane 4e (120 mg, 0.300 mmol, 1.0 eq), a mixture of diastereoisomers (12:1 by integration of 
methyl esters at 3.56 ppm and 3.54 ppm) 6eg (111 mg, 0.270 mmol, 90% NMR yield)20 was obtained after 
column chromatography as a white foam. After recrystallization in ethanol, the pure product 6eg (97 mg, 
0.24 mmol, 79% isolated yield) was obtained as white foam and as a mixture of diastereoisomers (7:1 by 
integration of methyl esters at 3.56 ppm and 3.54 ppm). 
Rf  0.24 (4:6 Pentane/Ethyl acetate). 
Mp 186.4-188.3°C. 
1H NMR (400 MHz, Chloroform-d, major diastereoisomer) δ 9.74 (s, 1 H, NH), 7.27 (d, J = 1.4 Hz, 1 H, , 
thymine C=C-H), 7.23 (dd, J = 5.1, 1.2 Hz, 1 H, thiophene-H), 7.04 (dd, J = 3.5, 1.1 Hz, 1 H, thiophene -
H), 6.92 (dd, J = 5.1, 3.6 Hz, 1 H, thiophene -H), 5.95 (dd, J = 10.9, 2.8 Hz, 1 H, tetrahydropyran-NCH), 
5.48 (d, J = 0.8 Hz, 1 H, tetrahydropyran-CH), 3.71 (s, 3 H, ester CH3), 3.56 (s, 3 H, ester CH3), 2.70 – 
2.61 (m, 1 H, tetrahydropyran-CH2), 2.32 – 2.24 (m, 1 H, tetrahydropyran-CH2), 2.23 – 2.14 (m, 1 H, 
tetrahydropyran-CH2), 1.95 (d, J = 1.3 Hz, 3 H, thymine-CH3), 1.92 (dd, J = 7.9, 2.3 Hz, 1 H, 
tetrahydropyran-CH2).  
13C NMR (101 MHz, Chloroform-d, major diastereoisomer) δ 170.2, 168.9, 163.6, 150.1, 139.8, 135.2, 
126.2, 126.2, 125.5, 111.7, 82.1, 79.1, 57.4, 52.9, 52.5, 31.1, 26.5, 12.8.  
IR 3195 (w), 3042 (w), 2954 (w), 2832 (w), 2362 (w), 2252 (w), 2252 (w), 1690 (s), 1441 (w), 1375 (w), 
1271 (s), 1103 (m), 1050 (w), 913 (m), 734 (m).  
HRMS (ESI) calcd for C18H20N2NaO7S+ [M+Na]+ 431.0883; found 431.0879. 
 
(E)-dimethyl 6-(5-methyl-2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl)-2-styryldihydro-2H-pyran-
3,3(4H)-dicarboxylate (6ee). 
 
Following the general procedure GP5, using cinnamaldehyde (5e) (57 µL, .45 mmol, 1.5 eq) cyclobutane 
4e (120 mg, 0.300 mmol, 1.0 eq), a mixture of diastereoisomers (2.5:1 by integration of methyl esters at 
3.72 ppm and 3.67 ppm) 6ee (104 mg, 0.243 mmol, 81% NMR yield)20 was obtained after column 
chromatography as a yellow foam. After recrystallization in ethanol, the pure product 6ee (89 mg, 0.21 
mmol, 69% isolated yield) was obtained as yellow foam and as a mixture of diastereoisomers (2.5:1 by 
integration of methyl esters at 3.72 ppm and 3.67 ppm). 
Rf  0.37 (3:7 Pentane/Ethyl acetate). 
Mp 73.7-75-5 °C. 
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1H NMR (400 MHz, Chloroform-d) δ 9.03 (s, 1H, N H, major diastereoisomer), 8.91 (s, 1 H, NH, minor 
diastereoisomer), 7.39 – 7.21 (m, 10 H, Ar-H, major and minor diastereoisomers), 7.18 (dd, J = 3.4, 2.0 
Hz, 2 H, thymine C=C-H, , major and minor diastereoisomers), 6.79 (dd, J = 15.7, 1.1 Hz, 1 H, vinyl CH, 
minor diastereoisomer), 6.61 – 6.49 (m, 2 H, vinyl CH, major diastereoisomer), 6.31 (dd, J = 15.7, 8.0 Hz, 
1 H, , vinyl CH, minor diastereoisomer), 6.02 (dd, J = 11.2, 2.8 Hz, 1 H, tetrahydropyran-NCH, minor 
diastereoisomer), 5.91 (dd, J = 11.0, 3.0 Hz, 1 H, tetrahydropyran-NCH, major diastereoisomer), 5.40 (d, J 
= 8.0 Hz, 1 H, tetrahydropyran-CH, minor diastereoisomer), 4.68 (d, J = 5.3 Hz, 1 H, tetrahydropyran-CH, 
major diastereoisomer), 3.87 (s, 3 H, ester CH3, minor diastereoisomer), 3.78 (s, 3 H, ester CH3, major 
diastereoisomer), 3.71 (s, 3 H, ester CH3, major diastereoisomer), 3.66 (s, 3 H, ester CH3, minor 
diastereoisomer), 2.65 (ddd, J = 13.6, 4.2, 2.7 Hz, 1 H, tetrahydropyran-CH2, major diastereoisomer), 2.58 
– 2.35 (m, 2 H, tetrahydropyran-CH2, minor diastereoisomer), 2.26 – 2.15 (m, 1 H, tetrahydropyran-CH2, 
major diastereoisomer), 2.15 – 1.98 (m, 2 H, tetrahydropyran-CH2, major diastereoisomer and minor 
diastereoisomer), 1.95 (d, J = 1.2 Hz, 3 H, thymine-CH3, major diastereoisomer), 1.93 (d, J = 1.3 Hz, 3 H, 
thymine-CH3, minor diastereoisomer), 1.92 – 1.87 (m, 1 H, tetrahydropyran-CH2, major diastereoisomer), 
1.56 – 1.43 (m, 1 H, tetrahydropyran-CH2, minor diastereoisomer).  
13C NMR (101 MHz, Chloroform-d) δ 170.0, 169.6, 169.0, 168.3, 163.7, 163.7, 150.2, 150.1, 137.8, 
136.5, 135.3, 135.3, 132.7, 128.8, 128.8, 128.6, 128.1, 127.1, 126.8, 125.2, 120.4, 111.6, 111.4, 81.8, 81.7, 
76.1, 57.0, 56.6, 53.4, 53.2, 53.0, 52.6, 30.7, 27.5, 26.8, 24.1, 12.8.21  
IR 3730 (w), 2955 (w), 2361 (s), 2336 (s), 1744 (m), 1699 (s), 1666 (m), 1442 (w), 1275 (m), 1099 (w), 
976 (w), 914 (w), 736 (m).  
HRMS (ESI) calcd for C22H24N2NaO7+ [M+Na]+ 451.1476; found 451.1474. 
 
Dimethyl (5-fluoro-2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl)-2-phenyldihydro-2H-pyran-3,3(4H)-
dicarboxylate (6fa) 
 
Following the general procedure GP5, using benzaldehyde (5a) (46 µL, 0.45 mmol, 1.5 eq) and 
cyclobutane 4f (121 mg, 0.300 mmol, 1.0 eq), a mixture of diastereoisomers (13:1 by integration of 
methyl esters at 3.52 ppm and 3.48 ppm) 6fa (78 mg, 0.19 mmol, 64% NMR yield)20 was obtained after 
column chromatography as a white foam. After recrystallization in ethanol, the pure product 6fa (68 mg, 
0.17 mmol, 56% yield) was obtained as white foam and as a mixture of diastereoisomers (>20:1 by 
integration of methyl esters at 3.52 ppm and 3.48 ppm). 
Rf  0.32 (5:5 Pentane/Ethyl acetate). 
Mp 80.1- 81.7°C. 
1H NMR (400 MHz, Chloroform-d, major diastereoisomer) δ 9.95 (s, 1 H, NH), 7.63 (d, J = 5.8 Hz, 1 H, 
Ar-H), 7.39 – 7.34 (m, 2 H, Ar-H), 7.33 – 7.27 (m, 3 H, Ar-H and F-uracil C=C-H), 6.01 – 5.93 (m, 1 H, 
tetrahydropyran-NCH), 5.23 (s, 1H, tetrahydropyran-CH), 3.67 (s, 3 H, ester CH3), 3.52 (s, 3 H, ester 
CH3), 2.71 – 2.62 (m, 1 H, tetrahydropyran-CH2), 2.40 – 2.19 (m, 2 H, tetrahydropyran-CH2), 2.02 – 1.95 
(m, 1 H, tetrahydropyran-CH2).  
                                                          
21 3 carbons of the minor diastereoisomer are not resolved. 
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13C NMR (101 MHz, Chloroform-d, major diastereoisomer) δ 170.1, 169.1, 156.98 (d, J = 26.6 Hz), 
148.9, 140.93 (d, J = 238.5 Hz), 137.2, 128.5, 127.7, 127.4, 124.12 (d, J = 33.6 Hz), 82.2, 82.1, 56.9, 52.8, 
52.1, 31.2, 26.5.   
IR 3204 (w), 3064 (w), 2955 (w), 2361 (m), 2257 (w), 1717 (s), 1457 (w), 1368 (w), 1265 (s), 1103 (m), 
1043 (w), 912 (s), 731 (s).  
HRMS (ESI) calcd for C19H19FN2NaO7+ [M+Na]+ 429.1068; found 429.1065. 
 
Dimethyl -2-(tert-butyldimethylsilyl)oxy)-4-(1,3-dioxoisoindolin-2-yl)-2-phenylcyclohexane-1,1-
dicarboxylate (8aa) 
 
Following the general procedure GP6, using dimethyl 2-(1,3-dioxoisoindolin-2-yl)cyclobutane-1,1-
dicarboxylate (4a) (63.5 mg, 0.200 mmol, 1 eq) and tert-butyldimethyl(1-phenylvinyl)oxy)silane (7a) 
(70.4 mg, 0.300 mmol, 1.5 eq), dimethyl -2-(tert-butyldimethylsilyl)oxy)-4-(1,3-dioxoisoindolin-2-yl)-2-
phenylcyclohexane-1,1-dicarboxylate (8aa) (105 mg, 0.190 mmol, 95 % yield) was obtained as a colorless 
solid. 
Mp 188.8-190.0°C.  
1H NMR (400 MHz, CDCl3) δ 7.83 (dd, J = 5.5, 3.0 Hz, 2 H, Phth), 7.72 (dd, J = 5.4, 3.1 Hz, 2 H, Phth), 
7.44 – 7.38 (m, 2 H, Ar), 7.26 – 7.21 (m, 3 H, Ar), 4.86 (tt, J = 12.5, 4.7 Hz, 1 H, N-C-H), 3.96 (dd, J = 
13.6, 12.6 Hz, 1 H, CH2), 3.66 (s, 3 H, OMe), 3.64 (s, 3 H, OMe), 2.91 (td, J = 14.2, 3.7 Hz, 1 H, CH2 
cyclohexane), 2.31 (dt, J = 13.8, 3.5 Hz, 1 H, CH2), 2.23 – 2.01 (m, 2 H, CH2 cyclohexane), 1.88 – 1.74 
(m, 1 H, CH2 cyclohexane), 1.06 (s, 9 H, Si-
tBu), 0.14 (s, 3 H, Si-Me), -0.55 (s, 3 H, Si-Me).  
13C NMR (101 MHz, CDCl3) δ 170.1, 169.9, 168.4, 143.0, 134.1, 132.1, 128.8, 127.8, 126.5, 123.3, 79.7, 
64.6, 52.3, 52.0, 46.6, 36.7, 29.4, 26.4, 25.3, 19.3, -1.3, -2.5.  
IR 2953 (w), 2890 (w), 2856 (w), 2361 (w), 2339 (w), 1735 (s), 1714 (s), 1373 (m), 1274 (m), 1245 (m), 
1039 (m), 1038 (m).  
The data for 8aa matches the reported values.5 
Dimethyl-2-(tert-butyldimethylsilyl)oxy)-4-(1,3-dioxoisoindolin-2-yl)-2-(4-
methoxyphenyl)cyclohexane-1,1-dicarboxylate (8ab) 
 
Following the general procedure GP6, using dimethyl 2-(1,3-dioxoisoindolin-2-yl)cyclobutane-1,1-
dicarboxylate (4a) (65.5 mg, 0.200 mmol, 1 eq) and tert-butyl(1-(4-
methoxyphenyl)vinyl)oxy)dimethylsilane (7b) (79.0 mg, 0.300 mmol, 1.5 eq), dimethyl -2-(tert-
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butyldimethylsilyl)oxy)-4-(1,3-dioxoisoindolin-2-yl)-2-(4-methoxyphenyl)cyclohexane-1,1-dicarboxylate 
(8ab) (105.2 mg, 0.181 mmol, 90%) was obtained as a colorless solid. 
1H NMR (400 MHz, CDCl3) δ 7.83 (dd, J = 5.5, 3.0 Hz, 2 H, Ar Phth), 7.71 (dd, J = 5.4, 3.1 Hz, 2 H, Ar 
Phth), 7.34 – 7.29 (m, 2 H, Ar), 6.91 – 6.64 (m, 2 H, Ar), 5.05 – 4.69 (m, 1 H, N-C-H), 3.92 (dd, J = 13.5, 
12.6 Hz, 1 H, CH2), 3.79 (s, 3 H, OMe), 3.67 (s, 3 H, OMe), 3.64 (s, 3 H, OMe), 2.89 (td, J = 14.2, 3.7 Hz, 
1 H, CH2), 2.30 (dt, J = 13.8, 3.5 Hz, 1 H, CH2), 2.22 – 1.96 (m, 2 H, CH2), 1.90 – 1.69 (m, 1 H, CH2), 
1.05 (s, 9 H, OTBS), 0.14 (s, 3 H, OTBS), -0.50 (s, 3 H, OTBS).  
13C NMR (101 MHz, CDCl3) δ 171.5, 171.2, 169.7, 160.12, 136.5, 135.4, 133.4, 131.2, 124.6, 113.0, 
80.7, 65.8, 56.5, 53.6, 53.2, 47.8, 38.2, 30.7, 27.7, 26.6, 20.6, -0.0, -1.1.  
IR 2953 (w), 2933 (w), 2856 (w), 1731 (s), 1712 (s), 1612 (w), 1373 (m), 1373 (m), 1254 (m), 1037 (s), 
840 (m).  
HRMS (ESI) calcd for C31H40NO8Si+ [M+H]+ 582.2518; found 582.2500. 
 
Dimethyl-2-(tert-butyldimethylsilyl)oxy)-4-(1,3-dioxoisoindolin-2-yl)-2-(4-fluorophenyl)cyclohexane-
1,1-dicarboxylate (8ac) 
 
Following the general procedure GP6, using dimethyl 2-(1,3-dioxoisoindolin-2-yl)cyclobutane-1,1-
dicarboxylate (4a) (63.5 mg, 0.200 mmol, 1 eq) and tert-butyl(1-(4-fluorophenyl)vinyl)oxy)dimethylsilane 
(7c) (76.0 mg, 0.300 mmol, 1.5 eq), dimethyl -2-(tert-butyldimethylsilyl)oxy)-4-(1,3-dioxoisoindolin-2-
yl)-2-(4-fluorophenyl)cyclohexane-1,1-dicarboxylate (8ac) (113 mg, 0.198 mmol, 99%) was obtained as a 
colorless solid. 
1H NMR (400 MHz, CDCl3) δ 7.83 (dd, J = 5.5, 3.0 Hz, 2 H, Ar Phth), 7.72 (dd, J = 5.4, 3.0 Hz, 2 H, Ar 
Phth), 7.48 – 7.34 (m, 2 H, Ar), 6.93 (dd, J = 9.3, 8.2 Hz, 2 H, Ar), 4.84 (tt, J = 12.6, 4.6 Hz, 1 H, N-C-H), 
3.97 (dd, J = 13.6, 12.6 Hz, 1 H, CH2), 3.67 (s, 3 H, OMe), 3.64 (s, 3 H, OMe), 2.88 (td, J = 14.2, 3.7 Hz, 
1 H, CH2), 2.31 (dt, J = 13.9, 3.4 Hz, 1 H, CH2), 2.22 – 1.94 (m, 2 H, CH2), 1.91 – 1.74 (m, 1 H, CH2), 
1.05 (s, 9 H, OTBS), 0.17 (s, 3 H, OTBS), -0.51 (s, 3 H, OTBS).  
13C NMR (101 MHz, CDCl3) δ 169.8, 169.7, 168.3, 134.0, 132.0, 130.5 (d, J = 8.0 Hz), 123.2, 113.1 (d, J 
= 21.1 Hz), 79.2, 64.4, 52.2, 51.8, 46.3, 36.7, 29.2, 26.2, 25.1, 19.1, -1.4, -2.5.22  
IR 2953 (w), 2952 (w), 2857 (w), 2856 (w), 1735 (s), 1715 (s), 1375 (m), 1245 (m), 1244 (m), 1039 (m).  
HRMS (ESI) calcd for C30H36FNNaO7Si+ [M+Na]+ 592.2137; found 592.2142. 
 
Dimethyl-2-(tert-butyldimethylsilyl)oxy)-4-(1,3-dioxoisoindolin-2-yl)-2-(4-
(methoxycarbonyl)phenyl)cyclohexane-1,1-dicarboxylate (8ad) 
                                                          
22 Carbon with fluoride not resolved. 
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Following the general procedure GP6, using dimethyl 2-(1,3-dioxoisoindolin-2-yl)cyclobutane-1,1-
dicarboxylate (4a) (63.5 mg, 0.200 mmol, 1 eq) and methyl 4-(1-(tert-
butyldimethylsilyl)oxy)vinyl)benzoate (7d) (88.0 mg, 0.300 mmol, 1.5 eq). A mixture of two 
diastereomers of dimethyl -2-(tert-butyldimethylsilyl)oxy)-4-(1,3-dioxoisoindolin-2-yl)-2-(4-
methoxycarbonyl)phenyl)cyclohexane-1,1-dicarboxylate (8ad) (99.6 mg, 0.163 mmol, 82%) was obtained 
as a colorless solid. 
dr = 2:1, Diastereoisomeric ratio was calculated in 1H crude NMR integrating peaks at 0.17 and 0.12. 
Analysis of isolated fractions of the chromatography column allowed the characterization of major cis 
diastereomer. 
1H NMR (400 MHz, CDCl3) δ 7.97 – 7.91 (m, 2 H, Ar), 7.84 (dd, J = 5.4, 3.0 Hz, 2 H, Ar Phth), 7.72 (dd, 
J = 5.4, 3.0 Hz, 2 H, Ar Phth), 7.55 – 7.48 (m, 2 H, Ar), 4.85 (tt, J = 12.5, 4.7 Hz, 1 H, N-C-H), 3.99 (dd, 
J = 13.6, 12.6 Hz, 1 H, CH2), 3.90 (s, 3 H, OMe), 3.66 (s, 3 H, OMe), 3.63 (s, 3 H, OMe), 2.90 (td, J = 
14.2, 3.7 Hz, 1 H, CH2), 2.32 (dt, J = 13.8, 3.4 Hz, 1 H, CH2), 2.21 – 2.01 (m, 2 H, CH2), 1.83 (dd, J = 
13.1, 3.5 Hz, 1 H, CH2), 1.05 (s, 9 H, OTBS), 0.17 (s, 3 H, OTBS), -0.56 (s, 3 H, OTBS).   
13C NMR (101 MHz, CDCl3) δ 169.6, 169.6, 168.3, 166.9, 148.1, 134.0, 131.9, 129.2, 128.8, 127.6, 
123.2, 79.4, 64.4, 52.2, 52.0, 51.9, 46.2, 36.5, 29.2, 26.2, 25.1, 19.1, -1.4, -2.5.  
IR 2955 (w), 2955 (w), 2902 (w), 2902 (w), 2901 (w), 2901 (w), 2860 (w), 1716 (s), 1375 (m), 1375 (m), 
1281 (m), 1281 (m), 1246 (w), 1040 (m), 1040 (m).  
HRMS (ESI) calcd for C32H39NNaO9Si+ [M+Na]+ 632.2286; found 632.2282. 
 
Dimethyl-2-(tert-butyldimethylsilyl)oxy)-4-(1,3-dioxoisoindolin-2-yl)-3-methyl-2-phenylcyclohexane-
1,1-dicarboxylate (8ae) 
 
Following the general procedure GP6, using dimethyl 2-(1,3-dioxoisoindolin-2-yl)cyclobutane-1,1-
dicarboxylate (4a) (63.5 mg, 0.200 mmol, 1 eq) and (Z)-tert-butyldimethyl(1-phenylprop-1-en-1-
yl)oxy)silane (7e) (74.6 mg, 0.300 mmol, 1.5 eq),  a mixture of two diastereomers of dimethyl -2-(tert-
butyldimethylsilyl)oxy)-4-(1,3-dioxoisoindolin-2-yl)-3-methyl-2-phenylcyclohexane-1,1-dicarboxylate 
(8ae) (102 mg, 0.181 mmol, 90%) was obtained as a colorless solid.  
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dr = 2:1, Diastereoisomeric ratio was calculated in 1H crude NMR integrating peaks at 4.75 and 4.33. 
Analysis of isolated fractions of the chromatography column allowed the characterization of each 
diastereomer. 
Major cis-diastereoisomer 
1H NMR (400 MHz, CDCl3) δ 7.99 – 7.86 (m, 2 H, Ar Phth), 7.86 – 7.73 (m, 2 H, Ar Phth), 7.70 – 7.59 
(m, 2 H, Ar), 7.32 – 7.24 (m, 3 H, Ar), 4.62 (td, J = 12.0, 4.7 Hz, 1 H, N-C-H), 4.38 (dq, J = 11.5, 6.8 Hz, 
1 H, CH-Me), 3.71 (s, 3 H, OMe), 3.53 (s, 3 H, OMe), 3.03 – 2.80 (m, 1 H, CH2), 2.42 – 2.25 (m, 2 H, 
CH2), 1.93 – 1.80 (m, 1 H, CH2), 1.17 (s, 9 H, OTBS), 0.92 (d, J = 6.8 Hz, 3 H, CH3), 0.42 (s, 3 H, 
OTBS), 0.00 (s, 3 H, OTBS).  
13C NMR23 (101 MHz, CDCl3) δ 169.8, 169.7, 168.6, 140.7, 134.1, 132.3, 131.6, 129.7, 127.2, 123.4, 
85.5, 65.8, 52.2, 52.2, 51.5, 36.3, 29.4, 26.6, 25.4, 20.4, 13.6, -0.1, -1.6.  
IR 2951 (w), 2950 (w), 2857 (w), 1736 (s), 1713 (s), 1372 (m), 1371 (m), 1276 (m), 1240 (m), 1134 (m), 
1051 (m), 836 (w).  
HRMS (ESI) calcd for C31H40NO7Si+ [M+H]+ 566.2569; found 566.2563. 
 
Minor trans-diastereoisomer  
1H NMR (400 MHz, CDCl3) δ 8.11 – 8.01 (m, 2 H, Ar Phth), 7.81 (ddd, J = 7.7, 1.3, 0.7 Hz, 1 H, Ar), 
7.63 (ddd, J = 7.0, 1.6, 0.7 Hz, 1 H, Ar), 7.56 – 7.37 (m, 5 H, Ar + Ar Phth), 4.76 (dd, J = 9.4, 7.2 Hz, 1 
H, CH-Me), 4.15 (ddd, J = 12.3, 9.4, 2.9 Hz, 1 H, N-C-H), 3.87 (s, 3 H, OMe), 3.40 (s, 3 H, OMe), 2.88 
(td, J = 14.2, 3.9 Hz, 1 H, CH2), 2.42 (dt, J = 14.2, 3.4 Hz, 1 H, CH2), 2.00 (dd, J = 13.3, 3.3 Hz, 1 H, 
CH2), 1.63 – 1.46 (m, 1 H, CH2), 1.18 (d, J = 7.2 Hz, 3 H, CH3), 0.94 (s, 9 H, OTBS), -0.03 (s, 3 H, 
OTBS), -0.34 (s, 3 H, OTBS).  
13C NMR the sample was degraded and a mixture of the product and a side product was present (probably 
the open product as there is a peak at 200 ppm).  
IR 2955 (w), 2859 (w), 1740 (m), 1703 (s), 1702 (s), 1329 (w), 1272 (m), 1221 (w), 1093 (m), 1072 (m), 
863 (w), 842 (w).  
HRMS (ESI). calcd for C31H40NO7Si+ [M+H]+ 566.2569; found 566.2568. 
 
                                                          
23 Peaks of impurities are present in the aromatic area. 
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5. Spectra of New Compounds 
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